https://curecurrent.com/trials/marginprobe-2-0-data-collection-protocol-29001https://curecurrent.com/trials/efficacy-and-safety-study-of-rem-001-photodynamic-therapy-for-treatment-of-cutaneous-metastatic-breast-cancer-cmbc-29002https://curecurrent.com/trials/tumour-registry-breast-cancer-29003https://curecurrent.com/trials/behavioral-and-psychological-impact-of-returning-breast-density-results-to-latinas-29004https://curecurrent.com/trials/the-impact-of-oral-cryotherapy-and-chewing-gum-interventions-29005https://curecurrent.com/trials/contigo-a-narrative-intervention-to-enhance-genetic-counseling-and-testing-29006https://curecurrent.com/trials/capecitabine-as-maintenance-therapy-vs-observation-in-early-stage-triple-negative-breast-cancer-29007https://curecurrent.com/trials/eurythmy-therapy-eryt-as-a-treatment-option-for-fatigue-in-metastatic-breast-cancer-patients-29008https://curecurrent.com/trials/3d-breast-ultrasound-elastography-in-patients-under-neoadjuvant-chemotherapy-29009https://curecurrent.com/trials/immune-responses-in-prostate-lung-melanoma-and-breast-cancer-patients-following-stereotactic-body-radiotherapy-sbrt-inte-29010https://curecurrent.com/trials/tape-application-protocol-for-enhanced-scars-29011https://curecurrent.com/trials/winq-a-window-of-opportunity-study-with-mitoq-in-breast-cancer-29012https://curecurrent.com/trials/shr-a1811-for-her2-positive-breast-cancer-with-suboptimal-neoadjuvant-response-29013https://curecurrent.com/trials/support-and-post-therapeutic-rehabilitation-for-women-in-complete-remission-of-breast-cancer-in-a-thermal-environment-29014https://curecurrent.com/trials/enhanced-assistance-during-radiotherapy-for-unmet-essential-needs-29015https://curecurrent.com/trials/a-correlational-study-breast-cancer-related-chest-wall-lymphedema-quality-of-life-and-shoulder-function-29016https://curecurrent.com/trials/restoring-sensitivity-to-immunotherapy-in-advanced-triple-negative-breast-cancer-exploiting-ceralasertib-priming-followe-29017https://curecurrent.com/trials/psychosexual-educational-partners-program-pepp-29018https://curecurrent.com/trials/feasibility-of-carbon-dye-marking-of-axillary-lymph-nodes-before-neoadjuvant-chemotherapy-in-patients-with-breast-cancer-29019https://curecurrent.com/trials/effectiveness-of-original-vs-ai-generated-plain-language-summaries-of-systematic-reviews-29020https://curecurrent.com/trials/the-effects-of-acupuncture-and-the-therapist-s-communication-on-chemotherapy-induced-nausea-and-vomiting-29021https://curecurrent.com/trials/physical-rehabilitation-program-for-cardiorespiratory-health-and-quality-of-life-among-breast-cancer-survivors-in-uae-29022https://curecurrent.com/trials/sacituzumab-tirumotecan-plus-anlotinib-for-metastatic-triple-negative-breast-cancer-29023https://curecurrent.com/trials/promoting-genetic-counseling-among-african-american-women-with-a-family-history-of-breast-cancer-29024https://curecurrent.com/trials/effects-of-transcutaneous-electrical-nerve-stimulation-on-breast-surgery-29025https://curecurrent.com/trials/high-resolution-lower-dose-dedicated-breast-computed-tomography-ct-29026https://curecurrent.com/trials/novel-lung-imaging-in-adults-undergoing-radiation-therapy-to-assess-for-radiation-pneumonitis-29027https://curecurrent.com/trials/mibreast-making-in-immediate-breast-reconstruction-and-the-measurement-of-the-effects-of-radiotherapy-29028https://curecurrent.com/trials/breast-cancer-prevention-and-screening-membership-29029https://curecurrent.com/trials/implantable-microdevice-for-in-vivo-drug-sensitivity-testing-in-patients-with-early-stage-her2-positive-or-triple-negati-29030https://curecurrent.com/trials/acupuncture-and-inflammatory-status-in-breast-cancer-patients-with-climateric-syndrome-29031https://curecurrent.com/trials/a-trial-of-shr-a1811versus-pyrotinib-in-combination-with-capecitabine-in-her2-positive-unresectable-and-or-metastatic-br-29032https://curecurrent.com/trials/efficacy-of-tqb2102-versus-tcbhp-in-neoadjuvant-therapy-for-her2-positive-early-breast-cancer-29033https://curecurrent.com/trials/neoadjuvant-study-of-pyrotinib-in-combination-with-trastuzumab-in-patients-with-her2-positive-breast-cancer-29034https://curecurrent.com/trials/ultra-hypofractionated-vs-moderately-hypofractionated-proton-therapy-for-early-breast-cancer-after-lumpectomy-29035https://curecurrent.com/trials/comparison-of-the-breast-tumor-microenvironment-29036https://curecurrent.com/trials/a-study-of-ly3039478-in-participants-with-advanced-or-metastatic-solid-tumors-29037https://curecurrent.com/trials/the-effects-of-erector-spinae-plane-block-on-pain-scores-in-unilateral-breast-cancer-surgery-29038https://curecurrent.com/trials/a-phase-i-clinical-study-of-intratumoral-injection-oncolytic-vaccinia-virus-gc001-in-patient-with-advanced-solid-tumors-29039https://curecurrent.com/trials/adebrelimab-combined-with-dalpiciclib-and-standard-endocrine-therapy-for-hr-her2-breast-cancer-29040https://curecurrent.com/trials/phase-i-ii-study-of-intrathecal-ommaya-t-dxd-in-her2-expressing-breast-cancer-with-leptomeningeal-brain-metastases-29041https://curecurrent.com/trials/evaluation-of-serum-il-7-as-a-biomarker-in-breast-cancer-29042https://curecurrent.com/trials/glycan-mediated-immune-regulation-with-a-bi-sialidase-fusion-protein-glimmer-01-29043https://curecurrent.com/trials/detection-of-tumor-dna-in-the-blood-of-patients-receiving-standard-therapy-for-hormone-receptor-positive-hr-non-her2-exp-29044https://curecurrent.com/trials/mammaprint-blueprint-and-full-genome-data-linked-with-clinical-data-to-evaluate-new-gene-expression-profiles-29045https://curecurrent.com/trials/safely-stopping-pre-medications-in-patients-with-breast-cancer-who-are-receiving-paclitaxel-29046https://curecurrent.com/trials/body-awareness-upper-extremity-function-and-quality-of-life-in-breast-cancer-survivors-29047https://curecurrent.com/trials/treatment-intermittent-periods-based-on-ctdna-mrd-circulating-tumor-dna-minimal-residual-disease-status-in-advanced-her2-29048https://curecurrent.com/trials/shr-a1811-combine-with-pyrotinib-for-locally-advanced-metastatic-her2-positive-breast-cancer-29049https://curecurrent.com/trials/pulsed-electromagnetic-field-therapy-to-a-tailored-exercise-program-for-patients-suffering-from-chemotherapy-induced-neu-29050https://curecurrent.com/trials/intraoperative-detection-of-breast-cancer-by-electrosurgical-gas-analysis-and-artificial-intelligence-29051https://curecurrent.com/trials/phosphatidylinositol-glycan-anchor-biosynthesis-class-u-protein-in-breast-cancer-29052https://curecurrent.com/trials/efficacy-and-safety-of-cdk4-6-inhibitors-combined-with-endocrine-therapy-in-hr-her2-neoadjuvant-therapy-for-early-breast-29053https://curecurrent.com/trials/evaluation-of-possible-safety-and-efficacy-of-fenofibrate-in-the-prophylaxis-of-doxorubicin-induced-cardiotoxicity-in-br-29054https://curecurrent.com/trials/a-study-of-parp1-selective-inhibitor-eik1004-imp1707-in-participants-with-advanced-solid-tumors-29055https://curecurrent.com/trials/intraoperative-radiation-therapy-iort-in-dcis-29056https://curecurrent.com/trials/a-study-of-neoadjuvant-treatment-with-tqb2102-for-injection-for-human-epidermal-growth-factor-receptor-2-her2-positive-b-29057https://curecurrent.com/trials/phase-ii-iii-study-of-sph4336-combined-with-letrozole-vs-placebo-combined-with-letrozole-in-first-line-treatment-of-brea-29058https://curecurrent.com/trials/talazoparib-monotherapy-in-palb2-mutation-associated-advanced-breast-cancer-29059https://curecurrent.com/trials/clinico-biological-data-collection-study-of-metastatic-breast-cancer-29060https://curecurrent.com/trials/a-study-of-adrx-0706-in-select-advanced-solid-tumors-29061https://curecurrent.com/trials/real-time-intraoperative-breast-cancer-visualization-for-margin-assessment-29062https://curecurrent.com/trials/a-study-of-prp-treatment-for-hair-loss-after-cancer-therapy-in-women-with-breast-cancer-29063https://curecurrent.com/trials/camrelizumab-in-combination-with-chemotherapy-as-neoadjuvant-treatment-in-patients-with-early-or-locally-advanced-triple-29064https://curecurrent.com/trials/decisions-of-young-women-with-breast-cancer-regarding-fertility-preservation-before-cancer-treatment-and-family-building-29065https://curecurrent.com/trials/shr2554-combined-with-endocrine-therapy-in-advanced-breast-cancer-29066https://curecurrent.com/trials/randomized-open-controlled-multicenter-phase-iii-clinical-study-of-fluzoparib-in-combination-with-apatinib-versus-invest-29067https://curecurrent.com/trials/veliparib-with-or-without-carboplatin-in-treating-patients-with-stage-iii-or-iv-breast-cancer-29068https://curecurrent.com/trials/conformal-partial-breast-irradiation-with-cyberknife-after-resection-for-early-stage-breast-cancer-29069https://curecurrent.com/trials/dose-escalation-study-of-mrna-2752-for-intratumoral-injection-to-participants-in-advanced-malignancies-29070https://curecurrent.com/trials/women-at-risk-of-breast-cancer-and-olfm4-29071https://curecurrent.com/trials/a-study-on-the-treatment-of-early-small-breast-cancer-with-ultrasound-guided-vacuum-assisted-excision-combined-with-surg-29072https://curecurrent.com/trials/performance-of-multi-cancer-early-detection-based-on-various-biomarkers-in-female-breast-cancers-perceive-breast-29073https://curecurrent.com/trials/a-targeted-electronic-health-approach-to-reduce-fear-of-recurrence-in-breast-cancer-survivors-fortitude-29074https://curecurrent.com/trials/clinical-trial-of-tqb2102-for-injection-versus-trastuzumab-emtansine-for-injection-in-her2-positive-advanced-breast-canc-29075https://curecurrent.com/trials/psychological-well-being-in-patients-with-breast-cancer-29076https://curecurrent.com/trials/phase-1-2-study-exploring-the-safety-tolerability-and-efficacy-of-incagn01876-combined-with-immune-therapies-in-advanced-29077https://curecurrent.com/trials/artificial-intelligence-in-breast-cancer-screening-programs-29078https://curecurrent.com/trials/pecha-kucha-method-effects-on-posttraumatic-growth-and-psychological-resilience-29079https://curecurrent.com/trials/impact-of-18f-fes-pet-on-the-therapeutic-treatment-of-patients-with-metastatic-breast-cancer-29080https://curecurrent.com/trials/open-label-study-to-assess-efficacy-and-safety-of-olaparib-in-confirmed-genetic-brca1-or-brca2-mutation-pats-29081https://curecurrent.com/trials/efficacy-of-pulsed-electromagnetic-field-therapy-on-acute-radiodermatitis-in-breast-cancer-patients-29082https://curecurrent.com/trials/breast-cancer-risk-investigation-in-grown-up-hodgkin-lymphoma-patients-treated-with-mbvd-multicenter-retrospective-study-29083https://curecurrent.com/trials/exploration-of-dalpiciclib-plus-hdaci-in-hr-her2-advanced-breast-cancer-after-failure-of-cdk4-6-inhibitor-29084https://curecurrent.com/trials/evaluating-investigational-medical-device-for-breast-tumor-diagnosis-using-diffusion-optical-spectroscopy-29085https://curecurrent.com/trials/study-of-molecular-characterisation-of-early-operable-primary-breast-cancer-in-pakistani-population-29086https://curecurrent.com/trials/evaluation-of-cognitive-management-for-chemobrain-in-patients-treated-for-breast-cancer-29087https://curecurrent.com/trials/a-study-on-the-efficacy-and-safety-of-oral-all-trans-retinoic-acid-combined-with-toripalimab-in-tnbc-29088https://curecurrent.com/trials/a-quasi-experimental-study-to-improve-breast-cancer-awareness-among-university-students-29089https://curecurrent.com/trials/neoadjuvant-chemotherapy-in-combination-with-toripalimab-for-hr-her2-breast-cancer-neotorch-breast01-29090https://curecurrent.com/trials/car-t-cells-in-mesothelin-expressing-breast-cancer-29091https://curecurrent.com/trials/hb1801-combined-treatment-of-her2-positive-breast-cancer-29092https://curecurrent.com/trials/patient-priorities-for-survivorship-care-in-older-breast-cancer-survivors-29093https://curecurrent.com/trials/exploration-of-the-safety-and-efficacy-of-t-dxd-concurrent-with-brain-radiotherapy-in-patients-with-brain-metastases-her-29094https://curecurrent.com/trials/neoadjuvant-chemotherapy-in-combination-with-anlotinib-and-benmelstobart-for-hr-her2-breast-cancer-neotorch-breast03-29095https://curecurrent.com/trials/smart-er-symptom-monitoring-with-patient-reported-outcomes-29096https://curecurrent.com/trials/ql1706-with-olaparib-for-previously-treated-her2-negative-breast-cancer-patients-with-homologous-recombination-deficienc-29097https://curecurrent.com/trials/phoenix-ddr-anti-pd-l1-trial-a-pre-surgical-window-of-opportunity-and-post-surgical-adjuvant-biomarker-study-of-dna-dama-29098https://curecurrent.com/trials/comparing-patient-reported-outcomes-and-clinical-outcomes-based-on-different-scar-placement-in-patients-undergoing-stand-29099https://curecurrent.com/trials/a-phase-i-iia-trial-of-hmbd-001-in-advanced-her3-positive-solid-tumours-29100https://curecurrent.com/trials/a-study-of-the-intratumoral-microdose-administration-of-pba-0405-in-patients-with-solid-tumors-29101https://curecurrent.com/trials/trastuzumab-rezetecan-combined-with-radiotherapy-versus-trastuzumab-rezetecan-in-the-treatment-of-her2-positive-advanced-29102https://curecurrent.com/trials/tumor-markers-for-efficacy-of-dual-target-therapy-in-her2-breast-cancer-29103https://curecurrent.com/trials/a-phase-0-multicenter-study-of-the-pharmacodynamic-effects-of-intratumoral-microdose-administration-of-pba-0111-in-patie-29104https://curecurrent.com/trials/decisions-about-cancer-screening-in-alzheimer-s-disease-29105https://curecurrent.com/trials/fertility-pregnancy-contraception-after-breast-cancer-in-france-29106https://curecurrent.com/trials/trial-of-zn-a-1041-enteric-capsules-in-patients-with-her2-positive-advanced-solid-tumors-29107https://curecurrent.com/trials/prospective-study-on-exemption-of-tumor-bed-boost-radiotherapy-for-pcr-patients-after-breast-conserving-surgery-with-neo-29108https://curecurrent.com/trials/molecular-breast-imaging-mbi-guided-biopsy-29109https://curecurrent.com/trials/effect-of-dietary-counseling-and-nutritional-monitoring-in-reducing-cancer-related-cachexia-among-female-oncology-patien-29110https://curecurrent.com/trials/pirfenidonevsplacebo-as-prophylaxis-against-acute-radiation-induced-lung-injury-following-hfrt-in-breast-cancer-patients-29111https://curecurrent.com/trials/establishment-of-molecular-profiling-for-individual-clinical-routine-treatment-decision-in-early-breast-cancer-29112https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-in-combination-with-atezolizumab-or-placebo-as-a-treatment-for-participants-with-human-29113https://curecurrent.com/trials/role-of-fgf21-in-breast-cancer-29114https://curecurrent.com/trials/bcd-236-in-combination-with-chemotherapy-in-patients-with-relapsed-and-or-metastatic-triple-negative-breast-cancer-29115https://curecurrent.com/trials/study-of-cirmtuzumab-and-paclitaxel-for-metastatic-or-locally-advanced-unresectable-breast-cancer-29116https://curecurrent.com/trials/a-manualized-post-traumatic-growth-intervention-for-people-with-cancer-in-greece-ic-growth-29117https://curecurrent.com/trials/skb264-combined-with-kl-a167-neoadjuvant-therapy-for-early-stage-high-risk-er-her2-breast-cancer-29118https://curecurrent.com/trials/psychological-distress-in-breast-cancer-patients-a-cross-sectional-study-in-iraq-29119https://curecurrent.com/trials/efficacy-and-safety-of-t-dxd-in-patients-with-her2-positive-and-her2-low-metastatic-breast-cancer-a-real-world-study-29120https://curecurrent.com/trials/adjustable-compression-wraps-acw-in-lymphedema-29121https://curecurrent.com/trials/phase-1-first-in-human-dose-finding-and-expansion-study-to-evaluate-xmab-808-in-combination-with-pembrolizumab-in-advanc-29122https://curecurrent.com/trials/a-phase-1-study-of-azd9833-in-japanese-women-with-er-positive-her2-negative-advanced-breast-cancer-29123https://curecurrent.com/trials/study-of-paclitaxel-micelles-for-injection-in-chinese-patients-with-advanced-solid-tumors-29124https://curecurrent.com/trials/a-qualitative-study-on-advanced-breast-cancer-patients-and-their-caregivers-in-spain-29125https://curecurrent.com/trials/gm1-prophylaxis-for-nab-paclitaxel-associated-chemotherapy-induced-peripheral-neuropathy-cipn-in-patients-with-breast-ca-29126https://curecurrent.com/trials/real-life-pan-her-blockade-with-neratinib-29127https://curecurrent.com/trials/real-world-study-using-comprehensive-genomic-data-on-the-next-treatment-decision-making-in-metastatic-breast-cancer-29128https://curecurrent.com/trials/evaluation-of-improvements-in-patient-reported-quality-of-life-29129https://curecurrent.com/trials/carbon-suspension-vs-metallic-marker-for-axillary-lymph-node-marking-in-breast-cancer-after-neoadjuvant-therapy-29130https://curecurrent.com/trials/this-study-aims-to-optimize-neoadjuvant-therapy-for-her2-positive-breast-cancer-by-implementing-a-dynamic-monitoring-gui-29131https://curecurrent.com/trials/triple-negative-breast-cancer-and-celecoxib-pilot-study-29132https://curecurrent.com/trials/prospective-multicenter-single-arm-trial-ak112-nab-paclitaxel-carboplatin-neoadjuvant-for-tnbc-29133https://curecurrent.com/trials/dalpiciclib-as-adjuvant-therapy-for-hr-positive-her2-negative-early-stage-patients-29134https://curecurrent.com/trials/study-of-dm5167-in-patients-with-advanced-solid-tumors-29135https://curecurrent.com/trials/a-randomized-study-of-js004-and-toripalimab-combined-with-chemotherapy-vs-toripalimab-combined-with-chemotherapy-vs-chem-29136https://curecurrent.com/trials/young-patients-with-early-breast-cancer-29137https://curecurrent.com/trials/metastatic-breast-cancer-specific-prognostic-tool-29138https://curecurrent.com/trials/carbon-nanoparticle-loaded-iron-cnsi-fe-ii-in-the-treatment-of-advanced-solid-tumor-29139https://curecurrent.com/trials/safety-study-of-3d-printing-personalized-biodegradable-implant-for-breast-reconstruction-29140https://curecurrent.com/trials/de-escalation-in-axillary-surgery-for-early-stage-breast-cancer-29141https://curecurrent.com/trials/rct-of-strategies-to-augment-physical-activity-in-black-and-hispanic-breast-and-prostate-cancer-survivors-allstar-29142https://curecurrent.com/trials/axillary-staging-in-node-positive-breast-cancer-patients-receiving-pst-snb-vs-pet-mri-29143https://curecurrent.com/trials/oligocare-twics-trials-within-cohorts-trial-comparing-acute-toxicity-in-single-fraction-vs-multiple-fraction-sbrt-for-me-29144https://curecurrent.com/trials/community-services-navigation-to-advance-health-equity-in-breast-cancer-screening-29145https://curecurrent.com/trials/identification-of-risk-factors-for-brain-recurrence-in-patients-with-her2-positive-localised-breast-cancer-29146https://curecurrent.com/trials/mgc018-with-or-without-mga012-in-advanced-solid-tumors-29147https://curecurrent.com/trials/use-of-intraoperative-radiotherapy-in-breast-cancer-29148https://curecurrent.com/trials/clinical-observational-studies-integrative-tcm-and-western-medicine-for-breast-cancer-29149https://curecurrent.com/trials/the-effectiveness-of-psychoeducational-intervention-in-reducing-anxiety-depression-and-symptom-burden-among-omani-women-29150https://curecurrent.com/trials/proof-of-concept-of-the-aiinane-preoperative-risk-assessment-tool-29151https://curecurrent.com/trials/dexmedetomidine-esketamine-combined-nasal-administration-and-perioperative-sleep-quality-29152https://curecurrent.com/trials/bioequivalence-study-of-paclitaxel-protein-bound-particles-for-injectable-suspension-albumin-bound-in-breast-cancer-pati-29153https://curecurrent.com/trials/nociception-level-monitor-nol-during-guided-analgesic-delivery-in-breast-surgeries-29154https://curecurrent.com/trials/impact-of-erector-spinae-plane-block-on-chronic-postsurgical-pain-in-breast-cancer-patients-29155https://curecurrent.com/trials/the-role-of-mucosal-associated-invariant-t-lymphocytes-in-breast-cancer-29156https://curecurrent.com/trials/the-breast-cancer-survivors-and-partners-online-research-together-suport-project-29157https://curecurrent.com/trials/additional-prognostic-value-of-tumor-grade-beyond-the-21-gene-recurrence-score-29158https://curecurrent.com/trials/sentinel-lymph-node-biopsy-after-neoadjuvant-treatment-in-breast-cancer-patents-29159https://curecurrent.com/trials/efficacy-and-safety-of-lobaplatin-and-carboplatin-as-neoadjuvant-therapy-in-her-2-positive-breast-cancer-29160https://curecurrent.com/trials/image-based-ai-predictive-biomarkers-for-precision-neoadjuvant-triple-negative-breast-cancer-treatment-29161https://curecurrent.com/trials/a-clinical-trial-of-the-safety-and-anti-tumor-activity-of-ab-201-in-subjects-with-advanced-her2-solid-tumors-29162https://curecurrent.com/trials/effect-of-circuit-weight-training-on-functional-capacity-and-quality-of-life-in-breast-cancer-patients-29163https://curecurrent.com/trials/study-of-an-ehealth-delivery-alternative-for-cancer-genetic-testing-for-hereditary-predisposition-in-metastatic-cancer-p-29164https://curecurrent.com/trials/efficacy-of-auricular-acupuncture-therapy-in-the-prevention-of-cipn-in-breast-cancer-29165https://curecurrent.com/trials/exploring-a-breast-cancer-early-screening-model-based-on-cfdna-29166https://curecurrent.com/trials/icg-and-sln-mapping-29167https://curecurrent.com/trials/study-to-evaluate-the-effect-of-metformin-in-the-prevention-of-hg-in-hr-her2-pik3ca-mut-advanced-bc-patients-29168https://curecurrent.com/trials/zoledronic-acid-combined-with-ec-t-for-triple-negative-breast-cancer-29169https://curecurrent.com/trials/digital-breast-tomosynthesis-for-the-dutch-national-breast-cancer-screening-program-29170https://curecurrent.com/trials/proactive-evaluation-of-function-to-avoid-cardiotoxicity-29171https://curecurrent.com/trials/sacituzumab-tirumotecan-in-neoadjuvant-treatment-of-early-stage-tnbc-29172https://curecurrent.com/trials/study-evaluating-abemaciclib-aromatase-inhibitors-in-hr-her2-advanced-breast-cancer-patients-hermione-7-29173https://curecurrent.com/trials/initial-cdk-4-6-inhibitor-plus-endocrine-therapy-versus-initial-chemotherapy-in-hr-positive-her2-negative-unresectable-o-29174https://curecurrent.com/trials/effect-of-pentoxifylline-on-preventing-chemotherapy-induced-toxicities-in-patients-with-breast-cancer-29175https://curecurrent.com/trials/5-fr-ultrahypofractionated-wbi-and-sib-for-breast-cancer-with-unfavorable-characteristics-29176https://curecurrent.com/trials/reliability-of-myoton-in-evaluating-skin-biomechanics-in-breast-cancer-related-lymphedema-29177https://curecurrent.com/trials/cryotherapy-for-the-prevention-of-taxane-induced-sensory-neuropathy-of-the-hands-and-feet-in-breast-cancer-patients-29178https://curecurrent.com/trials/data-analysis-for-drug-repurposing-for-effective-alzheimer-s-medicines-dream-anastrozole-vs-exemestane-letrozole-29179https://curecurrent.com/trials/study-of-syn608-for-the-treatment-of-advanced-or-metastatic-solid-tumors-29180https://curecurrent.com/trials/retrospective-study-of-2nd-line-therapies-after-cdk4-6i-hormonal-therapy-in-hr-her2-advanced-breast-cancer-29181https://curecurrent.com/trials/pembrolizumab-and-adg106-in-advanced-solid-cancers-and-triple-negative-breast-cancer-29182https://curecurrent.com/trials/a-phase-ib-safety-lead-in-followed-by-phase-ii-trial-of-adg106-in-combination-with-neoadjuvant-chemotherapy-in-her2-nega-29183https://curecurrent.com/trials/somatic-acupressure-for-symptom-cluster-management-in-breast-cancer-survivors-29184https://curecurrent.com/trials/using-a-blood-test-to-monitor-metastatic-breast-cancer-treatment-29185https://curecurrent.com/trials/lenvatinib-letrozole-versus-fulvestrant-in-metastatic-er-her2-breast-cancer-post-progression-on-al-cdk4-6-inhibitor-29186https://curecurrent.com/trials/selinexor-talazoparib-in-advanced-refractory-solid-tumors-advanced-metastatic-triple-negative-breast-cancer-start-29187https://curecurrent.com/trials/external-hypofractionated-radiotherapy-with-simultaneous-integrated-boost-in-early-breast-cancer-patients-29188https://curecurrent.com/trials/a-study-of-real-world-outcomes-of-ribociclib-in-first-line-treatment-for-metastatic-hr-her2-breast-cancer-29189https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-hb1801-with-taxotere-in-advanced-breast-cancer-29190https://curecurrent.com/trials/transcranial-direct-current-stimulation-for-cancer-related-cognitive-impairment-in-breast-cancer-survivors-29191https://curecurrent.com/trials/the-effect-of-health-education-conducted-using-two-different-methods-on-women-s-knowledge-of-breast-cancer-health-belief-29192https://curecurrent.com/trials/symptom-monitoring-using-patient-report-to-improve-medication-use-29193https://curecurrent.com/trials/safety-of-tt-00420-tinengotinib-monotherapy-in-patients-with-advanced-solid-tumors-and-triple-negative-breast-cancer-29194https://curecurrent.com/trials/nm32-2668-in-adult-patients-with-selected-advanced-solid-tumors-29195https://curecurrent.com/trials/analgesic-effect-of-serratus-plane-block-with-adjuvant-agents-in-breast-cancer-surgery-29196https://curecurrent.com/trials/trial-of-exercise-to-reduce-cancer-related-fatigue-in-breast-cancer-29197https://curecurrent.com/trials/multi-omics-study-of-the-effect-and-mechanisms-of-acupuncture-on-psychoneurological-symptoms-among-breast-cancer-survivo-29198https://curecurrent.com/trials/a-study-of-high-dose-vit-d-versus-standard-of-care-vit-d-supplementation-29199https://curecurrent.com/trials/copanlisib-in-combination-with-t-dm1-in-pretreated-unresectable-locally-advanced-or-metastatic-her2-positive-breast-canc-29200https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-versus-trastuzumab-as-adjuvant-therapy-in-patients-with-her2-positive-breast-cancer-who-29201https://curecurrent.com/trials/efficacy-and-safety-of-trastuzumab-biosimilar-herzuma-plus-treatment-of-physician-s-choice-tpc-in-patients-with-her-2-po-29202https://curecurrent.com/trials/postoperative-pain-central-sensitization-and-sleep-quality-in-breast-cancer-surgery-patients-29203https://curecurrent.com/trials/adverse-childhood-experiences-adaptation-and-breast-cancer-29204https://curecurrent.com/trials/a-study-to-compare-pk-immunogenicity-and-safety-of-trastuzumab-of-incepta-pharmaceuticals-ltd-with-trastuzumab-roche-29205https://curecurrent.com/trials/fasting-mimicking-diet-as-an-adjunct-to-neoadjuvant-chemotherapy-for-hormone-receptor-positive-breast-cancer-29206https://curecurrent.com/trials/deferoxamine-plus-chemotherapy-for-metastatic-triple-negative-breast-cancer-29207https://curecurrent.com/trials/chidamide-combined-with-zimberelimab-in-the-treatment-of-metastatic-triple-negative-breast-cancer-patients-29208https://curecurrent.com/trials/clinical-trial-of-metastasis-inhibitor-np-g2-044-in-patients-with-advanced-or-metastatic-treatment-refractory-solid-tumo-29209https://curecurrent.com/trials/non-invasive-brain-stimulation-and-cognitive-training-for-depressive-symptomatology-related-to-breast-cancer-oncodep-29210https://curecurrent.com/trials/clinical-study-of-the-efficacy-and-safety-of-bcd-178-and-perjeta-as-neoadjuvant-therapy-of-her2-positive-breast-cancer-29211https://curecurrent.com/trials/analgesic-efficacy-of-maxigesic-in-breast-cancer-surgery-29212https://curecurrent.com/trials/study-of-syn818-for-the-treatment-of-advanced-or-metastatic-solid-tumors-29213https://curecurrent.com/trials/impact-of-endocrine-therapy-and-abemaciclib-on-host-and-tumor-immune-cell-repertoire-function-in-advanced-er-her2-breast-29214https://curecurrent.com/trials/heat-and-cold-therapy-for-chemotherapy-induced-neuropathy-29215https://curecurrent.com/trials/increasing-midwifery-students-awareness-of-breast-and-gynecological-cancers-using-creative-drama-method-29216https://curecurrent.com/trials/the-effect-of-stress-ball-use-on-stress-anxiety-and-vital-signs-in-patients-undergoing-chemotherapy-for-breast-cancer-29217https://curecurrent.com/trials/inosine-reverse-chemo-resistance-in-triple-negative-breast-cancer-29218https://curecurrent.com/trials/real-world-study-of-post-resistance-treatment-strategies-in-advanced-breast-cancer-following-cdk4-6i-pik3ca-inhibitors-o-29219https://curecurrent.com/trials/an-indirect-treatment-comparison-of-the-effectiveness-of-ribociclib-combined-with-non-steroidal-aromatase-inhibitors-vs-29220https://curecurrent.com/trials/psma-pet-ct-to-assess-the-expression-of-specific-membrane-antigen-psma-in-patients-with-progressive-triple-negative-brea-29221https://curecurrent.com/trials/early-detection-of-breast-cancer-among-syrian-women-29222https://curecurrent.com/trials/electrochemical-biosensor-based-on-lectin-functionalized-nitrogen-sulfur-doped-graphene-quantum-dot-decorated-gold-nanop-29223https://curecurrent.com/trials/effectiveness-of-a-novel-low-level-laser-therapy-protocol-in-managing-breast-cancer-related-lymphedema-29224https://curecurrent.com/trials/a-randomized-open-label-multi-center-phase-iii-study-comparing-the-efficacy-of-oral-chemotherapy-combined-with-trastuzum-29225https://curecurrent.com/trials/a-study-of-xzp-3287-in-combination-with-letrozole-anastrozole-in-patients-with-advanced-breast-cancer-29226https://curecurrent.com/trials/non-inferiority-study-of-contrast-enhanced-digital-mammography-cedm-vs-magnetic-resonance-imaging-mri-in-terms-of-diagno-29227https://curecurrent.com/trials/oncologic-outcomes-of-minimal-access-nipple-sparing-mastectomy-compared-with-conventional-approach-in-breast-cancer-29228https://curecurrent.com/trials/analysis-of-surgery-in-patients-presenting-with-stage-iv-breast-cancer-29229https://curecurrent.com/trials/breast-cyclosporin-a-tnbc-triple-negative-breast-cancer-29230https://curecurrent.com/trials/the-beacon-trial-diagnostic-tools-for-breast-lymphedema-after-treatment-for-breast-cancer-29231https://curecurrent.com/trials/the-use-of-combined-motor-imagery-and-action-observation-to-evaluate-the-influence-on-functional-parameters-such-as-stre-29232https://curecurrent.com/trials/melatonin-in-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-29233https://curecurrent.com/trials/implant-based-breast-reconstruction-in-post-bariatric-women-a-registry-based-national-study-29234https://curecurrent.com/trials/erector-spinae-block-vs-placebo-block-study-29235https://curecurrent.com/trials/clinical-validation-of-an-mced-test-in-symptomatic-populations-k-accelerate-29236https://curecurrent.com/trials/efficacy-and-safety-comparison-of-niraparib-to-placebo-in-participants-with-human-epidermal-growth-factor-2-negative-her-29237https://curecurrent.com/trials/program-of-physical-activity-nutrition-and-supportive-to-improve-the-quality-of-life-of-breast-cancer-survivors-29238https://curecurrent.com/trials/a-multi-center-randomized-open-label-phase-iii-study-comparing-pd-1-inhibitor-combined-with-antivascular-therapy-and-ant-29239https://curecurrent.com/trials/safety-and-efficacy-of-ga68-iac-pet-ct-for-diagnosis-and-clinical-management-in-metastatic-breast-cancer-patients-29240https://curecurrent.com/trials/memory-and-attention-adaptation-training-geriatrics-maat-g-phase-ii-29241https://curecurrent.com/trials/pet-ct-for-trop2-adc-response-evaluation-cancers-29242https://curecurrent.com/trials/bi-836845-in-estrogen-receptor-positive-metastatic-breast-cancer-29243https://curecurrent.com/trials/rc48-plus-bevacizumab-or-pyrotinib-in-her2-positive-metastatic-breast-cancer-after-t-dxd-failure-a-phase-ii-study-29244https://curecurrent.com/trials/oxaloacetate-for-the-improvement-of-cognitive-complaints-in-stage-0-iiia-breast-cancer-survivors-29245https://curecurrent.com/trials/elvn-002-in-her2-mutant-non-small-cell-lung-cancer-29246https://curecurrent.com/trials/modulating-the-skin-microbiome-to-prevent-radiation-dermatitis-in-breast-cancer-29247https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-plus-hormone-therapy-in-participants-with-early-breast-cancer-29248https://curecurrent.com/trials/mechanisms-of-response-and-resistance-to-innovative-treatments-in-patients-with-locally-advanced-or-metastatic-breast-ca-29249https://curecurrent.com/trials/a-compassionate-use-study-of-leronlimab-in-breast-cancer-29250https://curecurrent.com/trials/effectiveness-of-a-combined-diet-and-mindfulness-program-on-weight-loss-in-breast-cancer-survivors-29251https://curecurrent.com/trials/artificial-intelligence-model-assisted-accurate-diagnosis-of-early-stage-breast-cancer-29252https://curecurrent.com/trials/a-comparative-study-of-nipple-sensation-preservation-after-nipple-sparing-mastectomy-with-conventional-endoscopic-roboti-29253https://curecurrent.com/trials/chemotherapy-with-or-without-trastuzumab-after-surgery-in-treating-women-with-invasive-breast-cancer-29254https://curecurrent.com/trials/a-study-of-fruquintinib-in-combination-with-tislelizumab-in-advanced-solid-tumors-29255https://curecurrent.com/trials/phase-ii-breast-ca-carboplatin-paclitaxel-with-pertuzumab-trastuzumab-or-bevacizumab-29256https://curecurrent.com/trials/focused-ultrasound-ablation-and-pd-1-antibody-blockade-in-advanced-solid-tumors-29257https://curecurrent.com/trials/catheter-tip-position-and-contrast-distribution-following-paravertebral-catheter-insertion-a-ct-study-29258https://curecurrent.com/trials/study-of-bone-mineral-density-in-women-with-breast-cancer-treated-with-triptorelin-and-tamoxifen-or-exemestane-on-protoc-29259https://curecurrent.com/trials/uptake-of-genetic-counseling-among-african-american-women-29260https://curecurrent.com/trials/feasibility-study-of-abc-for-women-treated-for-breast-cancer-29261https://curecurrent.com/trials/real-world-study-on-cdk4-6-inhibitors-combined-with-endocrine-therapy-and-subsequent-treatment-in-hr-her2-mbc-29262https://curecurrent.com/trials/incb106385-alone-or-in-combination-with-immunotherapy-in-advanced-solid-tumors-29263https://curecurrent.com/trials/human-ai-collaborative-insight-diagnostic-workflow-for-in-breast-cancer-with-extensive-intraductal-component-29264https://curecurrent.com/trials/comparing-endocrine-therapy-combined-with-high-dose-palbociclib-and-hydroxychloroquine-to-endocrine-therapy-combined-wit-29265https://curecurrent.com/trials/oral-paclitaxel-encequidar-vs-iv-paclitaxel-in-treatment-of-her2-negative-metastatic-breast-cancer-29266https://curecurrent.com/trials/seroma-formation-after-modified-radical-mastectomy-with-flap-fixation-technique-in-breast-cancer-patients-29267https://curecurrent.com/trials/effectiveness-of-a-video-and-mobile-app-in-breast-cancer-screening-awareness-29268https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-versus-placebo-in-combination-with-neoadjuvant-chemotherapy-adjuvant-endocrine-therapy-in-29269https://curecurrent.com/trials/adjuvant-treatment-of-ec-followed-by-taxane-carboplatin-in-triple-negative-breast-cancer-29270https://curecurrent.com/trials/phase-2-trial-of-neoadjuvant-weekly-carboplatin-plus-paclitaxel-in-triple-negative-breast-cancer-29271https://curecurrent.com/trials/posnoc-a-trial-looking-at-axillary-treatment-in-early-breast-cancer-29272https://curecurrent.com/trials/a-beta-only-il-2-immunotherapy-study-29273https://curecurrent.com/trials/clinical-study-with-lymfactin-in-the-treatment-of-patients-with-secondary-lymphedema-adele-29274https://curecurrent.com/trials/upper-extremity-exercise-capacity-of-breast-cancer-29275https://curecurrent.com/trials/use-of-imatinib-to-convert-triple-negative-breast-cancer-into-er-positive-breast-cancer-i-conic-29276https://curecurrent.com/trials/comparative-expression-of-er-pr-and-her2-neu-in-initial-and-recurrent-breast-cancer-29277https://curecurrent.com/trials/efficacy-of-nab-php-versus-tcbhp-in-neoadjuvant-therapy-for-her2-positive-early-breast-cancer-29278https://curecurrent.com/trials/association-between-work-related-stress-and-peripheral-neuropathic-pain-in-female-breast-cancer-post-ct-29279https://curecurrent.com/trials/reconstructions-with-back-donor-site-flaps-and-validation-of-quality-of-life-scales-29280https://curecurrent.com/trials/lighting-intervention-for-cancer-related-fatigue-29281https://curecurrent.com/trials/fenofibrate-role-in-breast-cancer-patients-29282https://curecurrent.com/trials/real-world-outcomes-of-patients-with-her2-metastatic-breast-cancer-after-treatment-with-trastuzumab-deruxtecan-29283https://curecurrent.com/trials/an-exploratory-evaluation-of-biomarkers-in-blister-fluid-in-healthy-volunteers-and-irradiated-skin-29284https://curecurrent.com/trials/role-of-the-immune-environment-in-response-to-therapy-in-breast-cancer-29285https://curecurrent.com/trials/exosomal-and-free-extracellular-rnas-and-proteins-as-predictive-biomarkers-for-her2-therapies-in-breast-cancer-29286https://curecurrent.com/trials/measurement-of-circulating-mutation-burden-29287https://curecurrent.com/trials/prevention-of-heart-failure-induced-by-doxorubicin-with-early-administration-of-dexrazoxane-29288https://curecurrent.com/trials/remote-assessment-of-cognition-insulin-resistance-and-omega-3-fatty-acid-biomarkers-in-breast-cancer-survivors-29289https://curecurrent.com/trials/characther-icorg-12-09-v3-29290https://curecurrent.com/trials/ovarian-reserve-in-premenopausal-breast-cancer-29291https://curecurrent.com/trials/efficacy-and-safety-of-ds8201-in-metastatic-breast-cancer-s-treatment-29292https://curecurrent.com/trials/use-of-handheld-fans-in-management-of-hot-flashes-in-women-with-breast-cancer-receiving-hormonetherapy-29293https://curecurrent.com/trials/circulating-mirnas-29294https://curecurrent.com/trials/can-do-versus-do-do-in-patients-with-breast-cancer-29295https://curecurrent.com/trials/evaluation-of-orally-administered-amcenestrant-sar439859-in-japanese-postmenopausal-patients-with-advanced-breast-cancer-29296https://curecurrent.com/trials/miti-gene-recurrence-score-in-hr-her2-chinese-breast-cancer-patients-29297https://curecurrent.com/trials/study-of-orm-5029-in-subjects-with-her2-expressing-advanced-solid-tumors-29298https://curecurrent.com/trials/breast-aesthetics-by-three-dimensional-measures-29299https://curecurrent.com/trials/a-study-of-pembrolizumab-with-carboplatin-and-gemcitabine-in-patients-with-metastatic-triple-negative-breast-cancer-29300https://curecurrent.com/trials/autologous-vs-implant-based-breast-reconstruction-29301https://curecurrent.com/trials/quality-of-life-aesthetic-result-and-health-economy-in-breast-reconstruction-29302https://curecurrent.com/trials/the-effect-of-mandala-on-anxiety-physiological-parameters-and-patient-satisfaction-in-women-with-breast-cancer-29303https://curecurrent.com/trials/validation-of-scales-in-reconstructive-breast-surgery-29304https://curecurrent.com/trials/effects-of-expectations-and-body-image-in-breast-reconstruction-29305https://curecurrent.com/trials/psychological-effects-of-implant-loss-29306https://curecurrent.com/trials/single-level-and-two-level-serratus-posterior-superior-intercostal-plan-block-spsipb-29307https://curecurrent.com/trials/the-effect-of-aerobic-exercise-on-selective-biomarkers-of-patients-with-cancer-29308https://curecurrent.com/trials/optimizing-postoperative-recovery-after-breast-reconstruction-with-autologous-tissue-bestdiep-29309https://curecurrent.com/trials/testing-the-addition-of-an-investigational-anti-cancer-drug-astx660-tolinapant-to-a-usual-chemotherapy-treatment-eribuli-29310https://curecurrent.com/trials/effect-of-breast-implants-om-mammography-screening-29311https://curecurrent.com/trials/comparison-of-operation-time-drain-duration-and-seroma-formation-after-modified-radical-mastectomy-using-ultrasonic-diss-29312https://curecurrent.com/trials/shr-1811-combined-with-carboplatin-in-the-treatment-of-advanced-breast-cancer-with-her2-expression-29313https://curecurrent.com/trials/sbrt-chemotherapy-and-ak112-neoadjuvant-therapy-for-luminal-type-breast-cancer-29314https://curecurrent.com/trials/trastuzumab-rezetecan-plus-pertuzumab-in-the-neoadjuvant-treatment-of-her2-positive-bc-29315https://curecurrent.com/trials/the-application-of-huaxi-hole-1-in-reverse-sequence-endoscopic-nipple-sparing-mastectomy-with-direct-to-implant-breast-r-29316https://curecurrent.com/trials/dosimetric-evaluation-of-breathing-impact-on-ptv-and-adjacent-organ-at-risk-in-breast-cancer-radiotherapy-29317https://curecurrent.com/trials/personalization-of-external-beam-radiation-therapy-in-localised-tumours-29318https://curecurrent.com/trials/treatment-for-persistently-fatigued-cancer-survivors-a-randomized-controlled-trial-with-biomarker-response-29319https://curecurrent.com/trials/concurrent-exercise-in-combination-with-music-listening-in-female-breast-cancer-survivors-29320https://curecurrent.com/trials/a-biomarker-screening-protocol-for-participants-with-solid-tumors-29321https://curecurrent.com/trials/metabolic-parameters-and-quality-of-life-in-women-on-neo-adjuvant-therapy-for-breast-cancer-29322https://curecurrent.com/trials/optimal-combination-of-adjuvant-radiotherapy-and-immunotherapy-for-breast-cancer-29323https://curecurrent.com/trials/trop-2-targeted-pet-probes-in-advanced-tnbc-29324https://curecurrent.com/trials/exercising-together-for-couples-coping-with-cancer-29325https://curecurrent.com/trials/expectations-and-priorities-of-elderly-patients-for-a-first-medical-treatment-for-cancer-29326https://curecurrent.com/trials/a-phase-ii-clinical-trial-of-artificial-intelligence-assisted-one-stop-radiotherapy-for-breast-cancer-after-breast-conse-29327https://curecurrent.com/trials/ibrance-real-world-insights-29328https://curecurrent.com/trials/a-study-to-investigate-lyl797-in-adults-with-solid-tumors-29329https://curecurrent.com/trials/radiotherapy-dose-adaptation-based-on-tumor-biology-in-patients-with-cn2b-n3-breast-cancer-29330https://curecurrent.com/trials/symptom-management-for-ya-cancer-survivors-29331https://curecurrent.com/trials/to-assess-the-contribution-of-sophrology-assisted-by-an-ambulatory-device-on-the-anxiety-of-patients-undergoing-chemothe-29332https://curecurrent.com/trials/safety-tolerability-potential-anti-cancer-activity-of-increasing-doses-of-azd5363-in-different-treatment-schedules-29333https://curecurrent.com/trials/prospective-observational-study-on-outcome-of-high-precision-hypo-fractionated-radiotherapy-in-metastatic-breast-cancer-29334https://curecurrent.com/trials/telephone-based-intervention-in-increasing-adherence-to-adjuvant-hormonal-therapy-in-patients-with-breast-cancer-29335https://curecurrent.com/trials/tomosynthesis-in-screening-mammography-29336https://curecurrent.com/trials/nilotinib-in-preventing-paclitaxel-induced-peripheral-neuropathy-in-patients-with-stage-i-iii-breast-cancer-29337https://curecurrent.com/trials/effect-of-preoperative-exercise-on-the-prevention-of-secondary-lymphedema-in-breast-cancer-patients-29338https://curecurrent.com/trials/a-study-of-hr-her2-metastatic-breast-cancer-patients-treated-with-palbociclib-together-with-an-aromatase-inhibitor-from-29339https://curecurrent.com/trials/oncologic-outcomes-and-toxicities-of-salvage-treatment-in-patients-with-locoregionally-recurrent-breast-cancer-29340https://curecurrent.com/trials/the-effect-of-education-given-on-preventing-mouth-ulcers-in-women-with-breast-cancer-29341https://curecurrent.com/trials/the-effect-of-animation-based-education-on-menopausal-women-s-attitudes-behaviors-and-screening-test-participation-regar-29342https://curecurrent.com/trials/pembrolizumab-and-binimetinib-in-treating-patients-with-locally-advanced-or-metastatic-triple-negative-breast-cancer-29343https://curecurrent.com/trials/a-study-of-npx267-for-subjects-with-solid-tumors-known-to-express-hhla2-b7-h7-29344https://curecurrent.com/trials/prognostic-indicators-for-radiation-induced-breast-fibrosis-29345https://curecurrent.com/trials/study-of-shr-a2102-combined-other-antitumor-drugs-in-advanced-breast-cancer-29346https://curecurrent.com/trials/exercise-and-compression-for-lymphedema-29347https://curecurrent.com/trials/clinical-impact-of-enhanced-risk-assessments-in-women-with-a-brca1-2-mutation-care-study-29348https://curecurrent.com/trials/measuring-oncological-value-of-exercise-and-statin-29349https://curecurrent.com/trials/photobiomodulation-for-prevention-of-chemotherapy-induced-peripheral-neuropathy-in-women-with-breast-cancer-29350https://curecurrent.com/trials/effectiveness-of-an-ehealth-self-management-support-program-for-persistent-pain-after-breast-cancer-treatment-29351https://curecurrent.com/trials/development-and-validation-of-an-ovarian-cancer-risk-prediction-model-for-family-members-of-ovarian-cancer-probands-29352https://curecurrent.com/trials/treatment-protocol-of-tucatinib-with-capecitabine-and-trastuzumab-in-patients-with-unresectable-previously-treated-her2-29353https://curecurrent.com/trials/the-efficacy-of-using-pentoxifylline-in-patients-undergoing-breast-cancer-surgery-29354https://curecurrent.com/trials/a-study-of-ds-8201a-in-metastatic-breast-cancer-previously-treated-with-trastuzumab-emtansine-t-dm1-29355https://curecurrent.com/trials/clinical-outcome-of-hormonal-receptor-positive-her-2-negative-breast-cancer-in-taiwan-29356https://curecurrent.com/trials/docosahexaenoic-acid-dha-for-women-with-breast-cancer-in-the-neoadjuvant-setting-29357https://curecurrent.com/trials/vsmart-video-conference-stress-management-and-relaxation-training-for-older-women-with-breast-cancer-29358https://curecurrent.com/trials/a-trial-assessing-feasibility-of-allostatic-load-biomarkers-and-cvd-risk-among-black-breast-cancer-survivors-29359https://curecurrent.com/trials/men1611-with-trastuzumab-fulvestrant-in-metastatic-breast-cancer-29360https://curecurrent.com/trials/neoadjuvant-adebrelimab-and-chemotherapy-in-high-rish-er-her2-bc-29361https://curecurrent.com/trials/a-study-to-see-whether-estrogen-can-slow-the-growth-of-some-er-positive-breast-cancers-29362https://curecurrent.com/trials/incidence-and-severity-of-diarrhea-in-patients-with-her2-positive-breast-cancer-treated-with-trastuzumab-and-neratinib-29363https://curecurrent.com/trials/water-and-land-based-aerobic-training-in-breast-cancer-survivors-29364https://curecurrent.com/trials/cryoablation-for-small-tumors-as-local-treatment-six-trial-29365https://curecurrent.com/trials/an-impact-assessment-of-a-culturally-tailored-online-psychosocial-program-for-chinese-immigrant-women-with-breast-cancer-29366https://curecurrent.com/trials/a-clinical-trail-of-kj015-in-patients-with-her2-expressing-solid-tumors-29367https://curecurrent.com/trials/continuous-serrates-plane-block-in-axillary-dissection-29368https://curecurrent.com/trials/personalized-vaccine-for-tnbc-immunotherapy-29369https://curecurrent.com/trials/a-clinical-study-of-tqb2102-versus-docetaxel-plus-trastuzumab-and-pertuzumab-in-the-treatment-of-her2-positive-recurrent-29370https://curecurrent.com/trials/genomic-and-transcriptomic-predictors-of-sequential-sg-sensitivity-after-t-dxd-in-er-her2-low-metastatic-breast-cancer-29371https://curecurrent.com/trials/mindful-after-cancer-a-mindfulness-based-therapy-intervention-for-sexual-health-after-cancer-29372https://curecurrent.com/trials/studying-blood-and-tumor-tissue-samples-in-women-with-invasive-breast-cancer-ductal-or-lobular-carcinoma-in-situ-or-beni-29373https://curecurrent.com/trials/a-real-world-clinical-study-of-t-dxd-for-the-treatment-of-chinese-patients-with-her2-overexpressing-and-her2-underexpres-29374https://curecurrent.com/trials/evaluation-of-the-effectiveness-and-safety-of-laparoscopic-assisted-mastectomy-with-preservation-of-nipple-and-areola-im-29375https://curecurrent.com/trials/regional-anesthesia-for-breast-surgery-29376https://curecurrent.com/trials/efficacy-and-safety-of-prepectoral-prosthesis-immediate-one-stage-breast-reconstruction-versus-two-stage-expander-prosth-29377https://curecurrent.com/trials/relationship-between-alterations-in-the-gi-microbiome-and-gi-inflammation-on-symptom-burden-in-women-with-breast-cancer-29378https://curecurrent.com/trials/a-guided-written-disclosure-intervention-to-promote-post-traumatic-growth-in-cancer-patients-guided-written-disclosure-29379https://curecurrent.com/trials/hs-10502-combination-treatment-in-patients-with-advanced-solid-tumors-29380https://curecurrent.com/trials/benson-relaxation-technique-effectiveness-on-pain-and-quality-of-life-post-reconstructive-mammoplasty-29381https://curecurrent.com/trials/diffusion-coefficient-and-micro-calcifications-to-kaiser-score-in-evaluation-of-bi-rads-4-breast-lesions-29382https://curecurrent.com/trials/this-study-in-patients-with-different-types-of-cancer-solid-tumours-aims-to-find-a-safe-dose-of-xentuzumab-in-combinatio-29383https://curecurrent.com/trials/sexual-dysfunction-check-up-in-premenopausal-breast-cancer-survivors-taking-endocrine-therapy-a-cross-sectional-study-29384https://curecurrent.com/trials/exercise-regimen-designed-to-improve-functional-mobility-body-composition-and-strength-after-treatment-for-breast-ca-29385https://curecurrent.com/trials/ds-8201a-for-treatment-of-abc-brain-mets-and-her2-disease-29386https://curecurrent.com/trials/shr-a2102-combined-with-adebrelimab-as-neoadjuvant-therapy-for-early-triple-negative-breast-cancer-29387https://curecurrent.com/trials/serplulimab-plus-chemotherapy-for-early-stage-hr-her2-breast-cancer-29388https://curecurrent.com/trials/nabpe-with-or-without-serplulimab-for-early-stage-hr-her2-breast-cancer-29389https://curecurrent.com/trials/shr-a1811-plus-pertuzumab-in-the-neoadjuvant-treatment-of-her2-positive-bc-29390https://curecurrent.com/trials/radiomics-to-predict-her2-status-and-t-dxd-efficacy-in-metastatic-breast-cancer-the-radiospher2-study-29391https://curecurrent.com/trials/application-of-targeted-axillary-lymph-node-resection-in-axillary-surgery-after-neoadjuvant-chemotherapy-for-breast-canc-29392https://curecurrent.com/trials/chemotherapy-monitoring-by-ctdna-in-her2-metastatic-breast-cancer-29393https://curecurrent.com/trials/clinical-trial-protocol-randomized-placebo-controlled-pilot-study-of-gcmaf-soloways-tm-in-patients-with-metastatic-breas-29394https://curecurrent.com/trials/analysis-of-the-real-world-prescription-pattern-of-palbociclib-combination-therapy-with-aromatase-inhibitor-as-a-first-l-29395https://curecurrent.com/trials/comparative-research-on-the-accuracy-of-margin-interpretation-in-breast-conserving-surgery-for-breast-cancer-cell-micros-29396https://curecurrent.com/trials/characterizing-fatigue-experienced-by-cancer-patients-receiving-primary-treatment-and-cancer-survivors-29397https://curecurrent.com/trials/a-phase-iii-study-of-esg401-for-locally-advanced-or-metastatic-hr-her2-breast-cancer-29398https://curecurrent.com/trials/dietary-and-exercise-interventions-in-reducing-side-effects-in-patients-with-stage-i-iiia-breast-cancer-receiving-aromat-29399https://curecurrent.com/trials/supermicrosurgical-lymphaticovenous-anastomosis-for-prevention-of-upper-limb-lymphedema-29400https://curecurrent.com/trials/mindful-eating-in-breast-cancer-survivors-a-pilot-study-in-t-rkiye-29401https://curecurrent.com/trials/pet-image-exploration-of-89zr-labeled-antibody-fragments-targeting-her2-in-patients-with-malignant-tumors-29402https://curecurrent.com/trials/the-exploration-of-novel-radionuclide-labeled-her2-targeting-antibodies-in-the-diagnosis-of-her2-positive-malignancies-29403https://curecurrent.com/trials/autologous-fat-infiltration-versus-general-measures-as-treatment-in-radiodermatitis-induced-for-radiotherapy-in-breast-c-29404https://curecurrent.com/trials/mobile-health-to-improve-oral-chemotherapy-adherence-among-women-with-breast-cancer-29405https://curecurrent.com/trials/identification-and-evaluation-of-patients-at-risk-of-developing-cardiotoxicity-after-receiving-chemotherapy-for-breast-c-29406https://curecurrent.com/trials/pemf-and-pec-blocks-in-mastectomy-reconstruction-patients-29407https://curecurrent.com/trials/financial-toxicity-in-breast-cancer-surgery-29408https://curecurrent.com/trials/real-time-molecular-analysis-of-breast-cancer-receiving-neo-adjuvant-chemotherapy-29409https://curecurrent.com/trials/tac-versus-tcx-as-adjuvant-treatment-for-high-risk-her2-negative-breast-cancer-29410https://curecurrent.com/trials/matrix-rotation-flap-versus-single-incision-lateral-sulcus-mammoplasty-29411https://curecurrent.com/trials/tolerance-to-immunomodulatory-nutritional-therapy-in-oncology-patients-undergoing-chemotherapy-and-radiotherapy-29412https://curecurrent.com/trials/concomitant-radiotherapy-and-new-drugs-in-metastatic-breast-cancer-29413https://curecurrent.com/trials/dose-escalated-concomitant-boost-radiotherapy-for-early-breast-cancer-29414https://curecurrent.com/trials/a-phase-ii-study-of-hlx22-in-combination-with-trastuzumab-deruxtecan-in-her2-low-hormone-receptor-positive-locally-advan-29415https://curecurrent.com/trials/analysis-of-letrozole-in-patients-with-operable-hormone-receptor-positive-her2-negative-breast-cancer-29416https://curecurrent.com/trials/post-operative-radiation-with-imrt-in-the-management-of-stage-iib-iii-breast-cancer-29417https://curecurrent.com/trials/grapiprant-and-eribulin-for-the-treatment-of-metastatic-inflammatory-breast-cancer-29418https://curecurrent.com/trials/effect-of-thera-band-versus-swiss-ball-exercises-on-postural-stability-in-post-mastectomy-lymphedema-29419https://curecurrent.com/trials/oral-metronomic-capecitabine-combined-with-pyrotinib-in-adc-treated-her2-positive-metastatic-breast-cancer-29420https://curecurrent.com/trials/effect-of-laughter-therapy-on-breast-cancer-patients-29421https://curecurrent.com/trials/evaluat-on-of-sympathet-c-nervous-system-f-nd-ngs-and-the-r-relat-onsh-p-w-th-symptoms-n-pat-ents-w-th-breast-cancer-rel-29422https://curecurrent.com/trials/a-study-of-the-effect-of-real-time-pressure-controllers-on-subjective-and-objective-symptoms-of-peripheral-neuropathy-in-29423https://curecurrent.com/trials/comparing-utd2-combined-with-capecitabine-to-capecitabine-as-adjuvant-therapy-for-non-pcr-tnbc-patients-29424https://curecurrent.com/trials/neratinib-in-extended-adjuvant-treatment-for-her2-early-breast-cancer-with-pcr-but-high-risk-features-a-hebei-multi-cent-29425https://curecurrent.com/trials/ketorolac-and-pregabalin-effects-on-breast-cancer-keprest-29426https://curecurrent.com/trials/a-study-of-lgk974-in-patients-with-malignancies-dependent-on-wnt-ligands-29427https://curecurrent.com/trials/self-compression-mammography-in-clinical-practice-29428https://curecurrent.com/trials/adherence-to-the-mediterranean-diet-among-women-attending-mammographic-screening-29429https://curecurrent.com/trials/study-of-ds-8201a-an-antibody-drug-conjugate-for-advanced-breast-cancer-patients-with-biomarkers-analysis-29430https://curecurrent.com/trials/radiation-therapy-with-or-without-trastuzumab-in-treating-women-with-ductal-carcinoma-in-situ-who-have-undergone-lumpect-29431https://curecurrent.com/trials/real-world-study-of-sacituzumab-govitecan-monotherapy-or-combination-therapy-in-recurrent-or-metastatic-her2-negative-br-29432https://curecurrent.com/trials/cognitive-training-and-exercise-for-women-with-breast-cancer-and-cognitive-impairment-29433https://curecurrent.com/trials/epcam-targeted-surface-enhanced-raman-spectroscopy-nanotags-for-rapid-evaluation-of-surgical-margins-and-sentinel-lymph-29434https://curecurrent.com/trials/to-evaluate-efficacy-and-safety-of-tt-00420-tinengotinib-as-monotherapy-and-combination-therapy-in-patients-with-advance-29435https://curecurrent.com/trials/the-effects-of-two-exercise-interventions-on-breast-cancer-patients-undergoing-cardiotoxic-chemotherapies-29436https://curecurrent.com/trials/study-of-cardiac-mri-in-patients-with-left-sided-breast-cancer-receiving-radiation-therapy-29437https://curecurrent.com/trials/effect-of-a-fruit-and-chaya-based-diet-on-genomic-instability-and-biochemical-markers-in-women-with-breast-cancer-receiv-29438https://curecurrent.com/trials/neratinib-and-capmatinib-combination-phase-ib-ii-in-metastatic-breast-cancer-and-inflammatory-breast-cancer-patients-wit-29439https://curecurrent.com/trials/pyrotinib-combined-with-dalpiciclib-combined-with-letrozole-in-er-positive-and-her2-positive-advanced-breast-cancer-29440https://curecurrent.com/trials/neobreastim-atezolizumab-plus-rp1-oncolytic-immunotherapy-in-the-neoadjuvant-setting-of-triple-negative-breast-cancer-29441https://curecurrent.com/trials/a-study-of-bms-986449-with-and-without-nivolumab-in-participants-with-advanced-solid-tumors-29442https://curecurrent.com/trials/physiotherapy-program-impact-on-breast-cancer-related-lymphedema-29443https://curecurrent.com/trials/avid100-in-advanced-epithelial-carcinomas-29444https://curecurrent.com/trials/effect-of-digital-combined-decongestive-therapy-in-patients-with-breast-cancer-related-lymphedema-a-follow-up-study-29445https://curecurrent.com/trials/glutamate-excitotoxicity-in-brain-metastases-from-lung-breast-and-melanoma-treated-with-stereotactic-radiosurgery-29446https://curecurrent.com/trials/early-diagnosis-of-breast-cancer-related-lymphedema-29447https://curecurrent.com/trials/immune-checkpoint-blockade-after-partial-breast-irradiation-by-pembrolizumab-in-early-tnbc-29448https://curecurrent.com/trials/add-aspirin-a-trial-assessing-the-effects-of-aspirin-on-disease-recurrence-and-survival-after-primary-therapy-in-common-29449https://curecurrent.com/trials/research-on-the-potential-mechanisms-underlying-the-efficacy-differences-in-specific-neoadjuvant-treatment-regimens-for-29450https://curecurrent.com/trials/rationale-and-trial-design-of-pfb-03-study-diagnostic-performance-and-clinical-application-of-18f-fapi-pet-ct-for-detect-29451https://curecurrent.com/trials/adaptive-therapy-for-post-second-line-advanced-breast-cancer-29452https://curecurrent.com/trials/abraxane-with-or-without-mifepristone-for-advanced-glucocorticoid-receptor-positive-triple-negative-breast-cancer-29453https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-hlx11-vs-eu-perjeta-in-the-neoadjuvant-therapy-of-her2-positive-and-hr-ne-29454https://curecurrent.com/trials/effects-of-bright-light-on-co-occurring-cancer-related-symptoms-in-breast-cancer-survivors-29455https://curecurrent.com/trials/myofascial-massage-for-pain-and-immobility-following-breast-cancer-surgery-29456https://curecurrent.com/trials/assessment-of-paclitaxel-induced-neuropathy-29457https://curecurrent.com/trials/monotherapy-with-eribulin-in-her2-negative-metastatic-breast-cancer-as-a-first-line-treatment-29458https://curecurrent.com/trials/ketogenic-diet-and-chemotherapy-in-affecting-recurrence-in-patients-with-stage-iv-breast-cancer-29459https://curecurrent.com/trials/safety-and-efficacy-of-ba1302-in-patients-with-advanced-solid-tumors-29460https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-btx-9341-in-advanced-and-or-metastatic-breast-cancer-29461https://curecurrent.com/trials/caloric-restriction-in-treating-patients-with-stage-0-i-breast-cancer-undergoing-surgery-and-radiation-therapy-29462https://curecurrent.com/trials/3d-printed-biodegradable-breast-implants-for-breast-restoration-29463https://curecurrent.com/trials/arsenous-acid-for-refractory-triple-negative-breast-cancer-29464https://curecurrent.com/trials/neoadjuvant-snf-precision-therapy-phase-iii-29465https://curecurrent.com/trials/the-use-of-ai-to-safely-reduce-the-workload-in-breast-cancer-screening-with-mammography-in-region-sterg-tland-29466https://curecurrent.com/trials/incidence-of-venous-thromboembolism-and-cardiovascular-events-in-breast-cancer-patients-undergoing-cyclin-dependent-kina-29467https://curecurrent.com/trials/early-detection-of-breast-cancer-in-women-with-suspicious-mammograms-29468https://curecurrent.com/trials/impact-of-nipple-reconstruction-in-mastectomized-patients-using-cross-linked-hyaluronic-acid-injection-29469https://curecurrent.com/trials/breaking-through-the-brain-fog-an-online-research-study-29470https://curecurrent.com/trials/pg2-injection-for-the-treatment-of-moderate-to-severe-fatigue-in-breast-cancer-patients-29471https://curecurrent.com/trials/a-mind-body-intervention-for-hot-flash-management-29472https://curecurrent.com/trials/chemo-free-in-older-65-node-positive-er-her2-breast-cancer-29473https://curecurrent.com/trials/pilot-study-with-the-aim-to-quantify-a-stress-protein-in-the-blood-and-in-the-urine-for-the-monitoring-and-early-diagnos-29474https://curecurrent.com/trials/ph-ii-study-of-pembrolizumab-eribulin-in-patients-with-hr-her2-mbc-previously-treated-with-anthracyclines-taxanes-29475https://curecurrent.com/trials/hormonal-receptor-hr-positive-her2-negative-breast-cancer-patients-treated-with-preoperative-elacestrant-and-pulsar-radi-29476https://curecurrent.com/trials/doxil-caelyx-be-study-29477https://curecurrent.com/trials/interventions-to-decrease-financial-toxicity-29478https://curecurrent.com/trials/clinical-study-of-ql1706-in-combination-with-olaparib-for-the-treatment-of-patients-with-previously-treated-homologous-r-29479https://curecurrent.com/trials/a-study-of-hansoh-hs-10502-in-patients-with-advanced-solid-tumors-29480https://curecurrent.com/trials/defining-musical-toxicity-and-its-effect-on-patient-well-being-29481https://curecurrent.com/trials/tcm-therapy-program-impact-on-breast-cancer-patients-vital-energy-29482https://curecurrent.com/trials/improved-breast-cancer-therapy-i-bct-1-in-the-neoadjuvant-and-metastatic-setting-29483https://curecurrent.com/trials/phase-ib-study-to-evaluate-the-safety-of-selinexor-kpt-330-in-combination-with-multiple-standard-chemotherapy-or-immunot-29484https://curecurrent.com/trials/immun-checkpoint-washout-in-patients-with-invasive-ductal-breast-cancer-29485https://curecurrent.com/trials/study-of-faslodex-concomitant-arimidex-v-exemestane-following-progression-on-non-steroidal-aromatase-inhibitors-29486https://curecurrent.com/trials/exploratory-study-of-precise-therapy-for-advanced-tumor-patients-with-malignant-hydrothorax-or-ascites-by-using-ptc-drug-29487https://curecurrent.com/trials/rta-408-lotion-in-patients-at-risk-for-radiation-dermatitis-primrose-29488https://curecurrent.com/trials/pembrolizumab-paclitaxel-in-hr-her2-non-luminal-by-pam50-advanced-breast-cancer-after-cdk4-6-inhibitor-progression-29489https://curecurrent.com/trials/survey-among-healthcare-professionals-treating-patients-with-metastatic-breast-cancer-in-selected-european-countries-to-29490https://curecurrent.com/trials/advanced-diffusion-tensor-mri-for-breast-cancer-29491https://curecurrent.com/trials/dance-movement-therapy-for-radio-oncological-patients-29492https://curecurrent.com/trials/resistance-training-to-prevent-lymphedema-after-breast-cancer-surgery-randomized-controlled-study-29493https://curecurrent.com/trials/clinical-efficacy-and-safety-of-paclitaxel-polymeric-micelles-for-injection-in-the-treatment-of-patients-with-taxans-res-29494https://curecurrent.com/trials/comparison-between-iort-and-postoperative-radiotherapy-in-breast-conserving-surgery-29495https://curecurrent.com/trials/ribociclib-pdr001-in-breast-cancer-and-ovarian-cancer-29496https://curecurrent.com/trials/predicting-long-term-clinical-outcomes-in-chinese-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-29497https://curecurrent.com/trials/exercise-in-triple-negative-breast-cancer-29498https://curecurrent.com/trials/circulating-tumor-dna-enriched-genomically-directed-post-neoadjuvant-trial-for-patients-with-residual-triple-negative-br-29499https://curecurrent.com/trials/study-of-bebt-209-in-combination-with-fulvestrant-versus-placebo-in-combination-with-fulvestrant-in-patients-with-hr-her-29500https://curecurrent.com/trials/a-prospective-cohort-study-of-proton-and-photon-therapy-for-left-sided-breast-cancer-29501https://curecurrent.com/trials/a-study-of-strataxrt-in-the-prevention-of-radiation-dermatitis-in-breast-cancer-patients-29502https://curecurrent.com/trials/chemotherapy-omission-in-hr-positive-her2-negative-breast-cancer-with-lymph-node-negative-disease-receiving-adjuvant-end-29503https://curecurrent.com/trials/randomized-phase-iii-trial-with-mepitel-film-for-the-prophylaxis-of-radiation-dermatitis-in-breast-cancer-patients-29504https://curecurrent.com/trials/chemotherapy-induced-lipid-profile-changes-in-women-with-early-breast-cancer-29505https://curecurrent.com/trials/efficacy-and-safety-of-kn026-in-combination-with-hb1801-in-the-first-line-treatment-of-subjects-with-her2-positive-recur-29506https://curecurrent.com/trials/extended-clinical-follow-up-and-biospecimen-collection-for-patients-enrolled-in-tailorx-and-rxponder-a-companion-protoco-29507https://curecurrent.com/trials/sbrt-in-early-breast-cancer-in-elderly-women-29508https://curecurrent.com/trials/breast-elasticity-imaging-during-neoadjuvant-chemotherapy-29509https://curecurrent.com/trials/acupuncture-for-anxiety-and-depression-29510https://curecurrent.com/trials/rta-744-in-breast-cancer-patients-with-progression-of-previously-irradiated-brain-metastases-29511https://curecurrent.com/trials/cytological-examination-of-malignant-pleural-effusion-in-breast-cancer-29512https://curecurrent.com/trials/radiation-induced-toxicity-of-the-heart-29513https://curecurrent.com/trials/clinical-application-of-pet-imaging-targeting-nectin-4-in-malignant-tumors-29514https://curecurrent.com/trials/decision-impact-study-of-precisedx-breast-29515https://curecurrent.com/trials/embrace-exercising-together-29516https://curecurrent.com/trials/circulating-tumor-dna-guided-boost-therapy-in-early-triple-negative-breast-patients-with-residual-disease-after-neoadjuv-29517https://curecurrent.com/trials/contrast-enhanced-mammography-in-women-with-a-personal-history-of-breast-cancer-and-dense-breast-tissue-benefit-29518https://curecurrent.com/trials/sacituzumab-govitecan-toripalimab-as-first-line-therapy-for-advanced-triple-negative-breast-cancer-and-biomarker-explora-29519https://curecurrent.com/trials/caregiver-depression-in-a-low-resource-setting-socio-demographic-predictors-of-major-depressive-disorder-among-family-ca-29520https://curecurrent.com/trials/patient-centric-study-to-assess-the-impact-of-genomic-profiling-on-the-treatment-of-patients-with-metastatic-breast-canc-29521https://curecurrent.com/trials/direct-tumor-microinjection-and-fdg-pet-in-testing-drug-sensitivity-in-patients-with-relapsed-or-refractory-non-hodgkin-29522https://curecurrent.com/trials/cabozantinib-in-women-with-metastatic-hormone-receptor-positive-breast-cancer-29523https://curecurrent.com/trials/digital-patient-support-program-for-self-efficacy-and-medication-adherence-in-women-on-adjuvant-endocrine-treatment-for-29524https://curecurrent.com/trials/photobiomodulation-in-radiodermatitis-in-people-with-breast-cancer-29525https://curecurrent.com/trials/study-to-determine-the-safety-tolerability-pharmacokinetics-and-recommended-phase-2-dose-rp2d-of-livmoniplimab-abbv-151-29526https://curecurrent.com/trials/a-study-on-the-efficacy-and-safety-of-ipyc-for-her2-mbc-29527https://curecurrent.com/trials/a-digital-solution-for-breast-cancer-patients-29528https://curecurrent.com/trials/a-study-of-nm21-1480-in-adult-patients-with-advanced-solid-tumors-29529https://curecurrent.com/trials/a-study-of-mirdametinib-on-its-own-or-in-combination-with-fulvestrant-in-people-with-solid-tumor-cancer-29530https://curecurrent.com/trials/monitoring-response-to-neoadjuvant-chemotherapy-in-her2-negative-breast-cancer-using-high-speed-mr-spectroscopic-imaging-29531https://curecurrent.com/trials/assessing-the-accuracy-of-tumor-biopsies-after-chemotherapy-to-determine-if-patients-can-avoid-breast-surgery-29532https://curecurrent.com/trials/heart-pillow-chemoteraphy-29533https://curecurrent.com/trials/ofs-in-premenopausal-node-breast-cancer-with-low-genomic-risk-29534https://curecurrent.com/trials/hypofractionated-radiotherapy-with-concomitant-tumor-bed-boost-for-breast-cancer-29535https://curecurrent.com/trials/evaluating-bemotuzumab-to-improve-the-efficacy-of-neoadjuvant-chemotherapy-for-triple-negative-breast-cancer-tnbc-29536https://curecurrent.com/trials/effect-of-cryotherapy-in-the-prevention-of-madarosis-produced-by-chemotherapy-in-breast-cancer-patients-29537https://curecurrent.com/trials/expanded-breast-cancer-registry-and-tissue-repository-29538https://curecurrent.com/trials/efficacy-of-acupuncture-treatment-for-breast-cancer-associated-insomnia-29539https://curecurrent.com/trials/a-study-of-contrast-enhanced-mammography-cem-scans-in-people-with-breast-cancer-29540https://curecurrent.com/trials/evaluating-image-quality-and-comfort-of-an-investigational-curved-paddle-compared-to-a-standard-paddle-29541https://curecurrent.com/trials/ultrasound-guided-multilevel-erectorspinae-plane-block-versus-thoracic-epidural-analgesia-for-prevention-of-post-mastect-29542https://curecurrent.com/trials/fih-bispecific-cd276xcd3-antibody-cc-3-in-patients-with-colorectal-cancer-29543https://curecurrent.com/trials/the-role-of-psychoeducation-in-breast-cancer-care-29544https://curecurrent.com/trials/tomosynthesis-mammographic-imaging-screening-trial-29545https://curecurrent.com/trials/efficacy-study-with-strataxrt-for-the-prophylaxis-of-radiation-dermatitis-in-adjuvant-breast-radiation-treatment-in-larg-29546https://curecurrent.com/trials/association-of-breast-reconstruction-method-with-long-term-risk-of-psychiatric-disorders-29547https://curecurrent.com/trials/t-vec-with-chemotherapy-or-endocrine-therapy-in-treating-participants-with-her2-negative-breast-cancer-29548https://curecurrent.com/trials/topical-betamethasone-versus-moisturizer-in-preventing-radiation-dermatitis-in-large-breasted-patients-treated-in-the-pr-29549https://curecurrent.com/trials/compassion-social-support-flexibility-and-resilience-program-for-women-surviving-breast-cancer-29550https://curecurrent.com/trials/cadonilimab-combined-with-chemotherapy-as-first-or-second-line-treatment-in-recurrent-or-metastatic-triple-negative-brea-29551https://curecurrent.com/trials/equita-a-feasibility-trial-of-a-faith-placed-intervention-to-increase-screening-uptake-in-black-adults-29552https://curecurrent.com/trials/vapocoolant-analgesia-for-breast-lymphoscintigraphy-29553https://curecurrent.com/trials/early-access-program-providing-her2-her3-bispecific-antibody-mcla-128-for-a-patient-with-advanced-nrg1-fusion-positive-s-29554https://curecurrent.com/trials/evaluation-of-barriers-to-cancer-care-delivery-and-outcomes-for-women-of-color-with-metastatic-breast-cancer-29555https://curecurrent.com/trials/a-study-of-jab-3312-in-adult-patients-with-advanced-solid-tumors-in-china-29556https://curecurrent.com/trials/microsurgical-treatment-of-breast-cancer-related-lymphedema-by-lymphaticovenous-anastomosis-29557https://curecurrent.com/trials/study-of-safety-and-efficacy-of-novel-immunotherapy-combinations-in-patients-with-triple-negative-breast-cancer-tnbc-29558https://curecurrent.com/trials/neoadjuvant-chemotherapy-in-combination-with-toripalimab-for-hr-her2-breast-cancer-a-randomized-open-label-parallel-cont-29559https://curecurrent.com/trials/an-imaging-study-in-er-negative-breast-cancer-by-targeting-v-6-29560https://curecurrent.com/trials/a-study-of-1-8f-fdht-pet-mriscans-in-women-with-breast-cancer-29561https://curecurrent.com/trials/18f-fluoroestradiol-pet-ct-imaging-of-invasive-lobular-carcinoma-29562https://curecurrent.com/trials/cfi-402257-a-potent-and-selective-ttk-inhibitor-in-solid-tumors-and-with-fulvestrant-in-breast-cancer-29563https://curecurrent.com/trials/neoadjuvant-therapy-with-ivonescimab-combined-with-chemotherapy-for-triple-negative-breast-cancer-29564https://curecurrent.com/trials/the-application-value-of-spectral-ct-in-the-accurate-staging-of-breast-cancer-29565https://curecurrent.com/trials/evaluation-of-the-efficacy-of-compression-with-tight-surgical-gloves-in-patients-with-taxane-based-therapy-29566https://curecurrent.com/trials/first-in-human-study-of-rly-5836-in-advanced-breast-cancer-and-other-solid-tumors-29567https://curecurrent.com/trials/rebecca-3-study-research-on-breast-cancer-induced-chronic-conditions-supported-by-causal-analysis-of-multi-source-data-29568https://curecurrent.com/trials/phase-ii-study-of-tetrathiomolybdate-tm-in-patients-with-breast-cancer-29569https://curecurrent.com/trials/romidepsin-and-abraxane-in-treating-patients-with-metastatic-inflammatory-breast-cancer-29570https://curecurrent.com/trials/muscle-oxygen-saturation-and-functional-capacity-in-breast-cancer-survivors-29571https://curecurrent.com/trials/a-phase-ii-study-of-shr-a1811-combined-with-radiotherapy-in-her2-positive-and-her2-low-breast-cancer-brain-metastases-29572https://curecurrent.com/trials/combination-of-abemaciclib-and-endocrine-therapy-in-hormone-receptor-positive-her2-negative-locally-advanced-or-metastat-29573https://curecurrent.com/trials/immune-pet-and-proteomics-for-the-assessment-of-response-to-spatially-fractionated-or-palliative-radiotherapy-with-or-wi-29574https://curecurrent.com/trials/the-effect-of-ultrasonography-guided-fascial-plane-blocks-in-breast-cancer-surgery-patients-29575https://curecurrent.com/trials/shr-a1811-and-thpy-in-first-or-second-line-for-her2-positive-advanced-breast-cancer-brain-metastases-29576https://curecurrent.com/trials/study-of-the-imaging-agent-18f-var3-in-patients-with-breast-cancer-29577https://curecurrent.com/trials/addition-of-cisplatin-to-adjuvant-chemotherapy-for-early-stage-breast-cancer-in-high-risk-women-29578https://curecurrent.com/trials/stromal-tumor-infiltrating-lymphocyte-levels-are-associated-with-immune-checkpoint-proteins-in-triple-negative-breast-ca-29579https://curecurrent.com/trials/ultrasound-imaging-technique-in-detecting-breast-microcalcifications-in-patients-undergoing-biopsy-for-a-breast-abnormal-29580https://curecurrent.com/trials/moving-forward-together-4-29581https://curecurrent.com/trials/immediate-breast-reconstruction-following-mastectomy-irma-29582https://curecurrent.com/trials/prospective-study-of-mastectomy-with-reconstruction-including-robot-endoscopic-surgery-29583https://curecurrent.com/trials/seviteronel-in-combination-with-chemotherapy-in-androgen-receptor-positive-metastatic-triple-negative-breast-cancer-29584https://curecurrent.com/trials/long-term-follow-up-study-of-early-stage-breast-cancer-patients-included-in-geicam-studies-29585https://curecurrent.com/trials/definitive-radiation-for-high-risk-spine-metastases-29586https://curecurrent.com/trials/effectiveness-of-introducing-ultra-high-b-value-diffusion-weighted-imaging-as-a-modified-abbreviated-protocol-for-breast-29587https://curecurrent.com/trials/analysis-of-recurrence-of-intraductal-papilloma-treated-with-vacuum-assisted-rotary-excision-29588https://curecurrent.com/trials/mecapegfilgrastim-for-the-prevention-of-dalpiciclib-induced-neutropenia-in-advanced-breast-cancer-29589https://curecurrent.com/trials/brain-imaging-nutrition-and-cognition-in-breast-cancer-survivors-29590https://curecurrent.com/trials/standard-or-hypofractionated-radiotherapy-versus-accelerated-partial-breast-irradiation-apbi-for-breast-cancer-29591https://curecurrent.com/trials/feasibility-trial-of-tele-ipt-and-tele-pharmacotherapy-for-patients-with-depression-and-non-metastatic-breast-cancer-29592https://curecurrent.com/trials/patient-education-strategy-for-breast-cancer-patients-during-perioperative-hospitalization-stage-29593https://curecurrent.com/trials/yoga-for-symptoms-of-nerve-damage-caused-by-chemotherapy-29594https://curecurrent.com/trials/early-ageing-during-therapy-in-aya-cancer-patients-29595https://curecurrent.com/trials/hypofractionated-pbi-after-bcs-for-low-risk-breast-cancer-patients-29596https://curecurrent.com/trials/auricular-acupressure-for-sleep-disorder-prevention-in-breast-cancer-29597https://curecurrent.com/trials/study-on-the-use-of-lateral-decubitus-position-in-left-breast-cancer-patients-undergoing-adjuvant-radiotherapy-29598https://curecurrent.com/trials/a-real-world-study-of-sacituzumab-govitecan-29599https://curecurrent.com/trials/a-randomized-study-of-th-versus-thl-in-first-line-treatment-of-her2-positive-metastatic-breast-cancer-29600https://curecurrent.com/trials/cannabidiol-cbd-for-treatment-of-aromatase-inhibitor-associated-arthralgias-29601https://curecurrent.com/trials/study-of-adagloxad-simolenin-obi-822-obi-821-in-the-adjuvant-treatment-of-patients-with-globo-h-positive-tnbc-29602https://curecurrent.com/trials/trastuzumab-deruxtecan-in-patients-with-triple-negative-metastatic-her2-low-breast-cancer-real-world-experience-in-brazi-29603https://curecurrent.com/trials/predicting-cancer-risk-with-digital-and-molecular-markers-29604https://curecurrent.com/trials/topical-calcipotriene-treatment-for-breast-cancer-immunoprevention-29605https://curecurrent.com/trials/assessment-of-breast-cancer-patients-satisfaction-and-health-related-quality-of-life-outcomes-29606https://curecurrent.com/trials/neorad-breast-cancer-study-29607https://curecurrent.com/trials/prediction-of-treatment-efficacy-of-the-combination-of-palbociclib-letrozole-or-anastrozole-in-first-line-metastatic-wom-29608https://curecurrent.com/trials/18f-fluoroestradiol-18f-fes-pet-ct-guided-first-line-treatment-for-hr-her2-metastatic-breast-cancer-patients-29609https://curecurrent.com/trials/investigation-of-the-effect-of-erector-spinae-plane-block-on-systemic-immuno-inflammatory-index-29610https://curecurrent.com/trials/precama-molecular-subtypes-of-premenopausal-breast-cancer-in-latin-american-women-29611https://curecurrent.com/trials/quantitative-subharmonic-breast-imaging-29612https://curecurrent.com/trials/a-study-of-pf-07260437-in-advanced-or-metastatic-solid-tumors-29613https://curecurrent.com/trials/tempus-priority-study-a-pan-tumor-observational-study-29614https://curecurrent.com/trials/the-impact-of-intelligent-patient-management-model-on-medication-adherence-of-pyrotinib-compared-to-traditional-patient-29615https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-dosimetry-and-preliminary-efficacy-of-the-her2-directed-radioligand-cam-h2-in-pa-29616https://curecurrent.com/trials/influence-of-preoperative-vitamin-d-level-on-postoperative-pain-in-breast-cancer-surgery-patients-29617https://curecurrent.com/trials/subharmonic-imaging-and-pressure-estimation-for-monitoring-neoadjuvant-chemotherapy-29618https://curecurrent.com/trials/prevention-of-oral-mucositis-and-improvement-of-quality-of-life-for-patients-with-breast-cancer-undergoing-adjuvant-radi-29619https://curecurrent.com/trials/safety-tolerability-pk-pd-preliminary-efficacy-of-skl27969-in-advanced-solid-tumors-patients-29620https://curecurrent.com/trials/study-of-the-combination-of-vorinostat-and-radiation-therapy-for-the-treatment-of-patients-with-brain-metastases-29621https://curecurrent.com/trials/sirolimus-for-injection-albumin-bound-in-combination-with-endocrine-therapy-for-hr-her2-advanced-metastatic-breast-cance-29622https://curecurrent.com/trials/positron-emission-tomography-imaging-using-copper-cu-64-tp3805-in-patients-with-breast-cancer-29623https://curecurrent.com/trials/prediction-of-icg-for-skin-necrosis-in-mastectomy-with-immediate-reconstruction-29624https://curecurrent.com/trials/standard-surveillance-vs-intensive-surveillance-in-early-breast-cancer-29625https://curecurrent.com/trials/a-study-of-ly2880070-in-participants-with-advanced-or-metastatic-cancer-29626https://curecurrent.com/trials/trilaciclib-combined-with-anti-pd-1-antibody-and-chemotherapy-in-the-treatment-of-locally-advanced-tnbc-29627https://curecurrent.com/trials/quantifying-systemic-immunosuppression-to-personalize-cancer-therapy-29628https://curecurrent.com/trials/investigational-drug-in-combination-with-two-chemotherapy-drugs-in-women-with-locally-recurrent-or-metastatic-breast-can-29629https://curecurrent.com/trials/a-randomized-secondary-adjuvant-treatment-intervention-study-comparing-trastuzumab-deruxtecan-to-soc-therapy-in-ebc-pati-29630https://curecurrent.com/trials/a-study-of-effect-of-megakaryocytes-and-platelets-in-breast-cancer-29631https://curecurrent.com/trials/pilot-study-of-anti-oxidant-supplementation-with-n-acetyl-cysteine-in-stage-0-i-breast-cancer-29632https://curecurrent.com/trials/discontinuation-of-cdk4-6-inhibitors-in-patients-with-metastatic-hr-positive-her2-negative-breast-cancer-29633https://curecurrent.com/trials/a-master-protocol-empowering-mechanobiology-translation-research-in-breast-cancer-29634https://curecurrent.com/trials/a-trial-of-amxi-5001-for-treatment-in-patients-with-advanced-malignancies-29635https://curecurrent.com/trials/ear-acupuncture-during-chemotherapy-infusion-for-breast-cancer-a-feasibility-study-29636https://curecurrent.com/trials/supervised-physical-activity-in-young-women-with-early-breast-cancer-during-neoadjuvant-chemotherpy-29637https://curecurrent.com/trials/mend-2-making-treatment-decisions-using-genomic-testing-29638https://curecurrent.com/trials/comparing-breast-magnetic-resonance-imaging-mri-and-contrast-enhanced-mammography-cem-29639https://curecurrent.com/trials/effects-of-two-strength-exercise-programs-on-upper-limb-functionality-in-breast-cancer-29640https://curecurrent.com/trials/integrin-v-6-targeted-pet-in-malignant-tumors-29641https://curecurrent.com/trials/engaged-2-study-experiences-with-mammography-screening-and-breast-density-2-29642https://curecurrent.com/trials/a-clinical-evaluation-of-ai-solutions-developed-in-the-chaimeleon-project-for-cancer-prostate-lung-breast-colon-and-rect-29643https://curecurrent.com/trials/using-the-active-breathing-control-device-to-reduce-radiation-side-effects-to-critical-structures-in-breast-cancer-29644https://curecurrent.com/trials/carboplatin-and-combination-chemotherapy-with-or-without-veliparib-in-treating-patients-with-stage-iib-iiic-breast-cance-29645https://curecurrent.com/trials/role-of-triggering-receptor-expressed-on-myeloid-cells-trem-1-as-a-novel-biomarker-in-human-epidermal-growth-factor-rece-29646https://curecurrent.com/trials/study-of-tyk-00540-tablets-in-patients-with-advanced-solid-tumors-29647https://curecurrent.com/trials/neoadjuvant-endocrine-therapy-in-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-her2-negative-node-n-29648https://curecurrent.com/trials/carevive-survivor-care-planning-system-in-improving-quality-of-life-in-breast-cancer-survivors-29649https://curecurrent.com/trials/to-evaluate-the-tolerability-and-pharmacokinetics-of-tqb2101-for-injection-in-patients-with-advanced-malignant-tumors-29650https://curecurrent.com/trials/clinical-study-of-18f-labeled-fapi-04-in-pet-imaging-of-breast-cancer-29651https://curecurrent.com/trials/tai-chi-for-relieving-aromatase-inhibitor-induced-arthralgia-in-patients-with-stage-i-iii-breast-cancer-the-taichi4joint-29652https://curecurrent.com/trials/breast-cancer-vaccine-in-combination-with-pembrolizumab-for-treatment-of-persistent-recurrent-or-metastatic-breast-cance-29653https://curecurrent.com/trials/carefor-precision-medicine-driving-precision-nutrition-for-the-treatment-of-neoadjuvant-breast-cancer-29654https://curecurrent.com/trials/caloric-restriction-before-surgery-in-treating-patients-with-endometrial-prostate-or-breast-cancer-29655https://curecurrent.com/trials/smart-phone-application-in-increasing-physical-activity-in-breast-cancer-survivors-29656https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-or-without-gnrh-agonist-for-premenopausal-triple-negative-early-breast-cancer-patients-29657https://curecurrent.com/trials/trastuzumab-deruxtecan-vs-endocrine-therapy-in-low-her2-hr-advanced-breast-cancer-29658https://curecurrent.com/trials/palbociclib-in-combination-with-adjuvant-endocrine-therapy-for-hormone-receptor-positive-her2-negative-invasive-breast-c-29659https://curecurrent.com/trials/contrast-enhanced-mammography-in-diagnosing-patients-with-suspicious-breast-findings-29660https://curecurrent.com/trials/genitourinary-syndrome-of-menopause-in-breast-cancer-29661https://curecurrent.com/trials/the-fema-study-feasibility-of-exercise-in-patients-with-metastatic-breast-cancer-and-adiposity-29662https://curecurrent.com/trials/comparison-between-erector-spinae-plane-block-versus-serratus-anterior-plane-block-regarding-analgesia-post-modified-rad-29663https://curecurrent.com/trials/development-of-a-personalized-discussion-prioritization-tool-for-older-adults-considering-adjuvant-chemotherapy-for-brea-29664https://curecurrent.com/trials/a-study-to-investigate-the-regional-brain-kinetics-of-brain-drug-transporters-using-p-glycoprotein-and-breast-cancer-res-29665https://curecurrent.com/trials/azacitidine-and-entinostat-in-treating-patients-with-advanced-breast-cancer-29666https://curecurrent.com/trials/a-real-world-study-of-ds-8201-29667https://curecurrent.com/trials/utd1-combined-with-capecitabine-in-metastatic-her2-negative-breast-cancer-patients-with-brain-metastases-29668https://curecurrent.com/trials/reflects-the-intervention-ai-chatbot-29669https://curecurrent.com/trials/breast-cancer-screening-with-mri-in-women-aged-50-75-years-with-extremely-dense-breast-tissue-the-dense-trial-29670https://curecurrent.com/trials/breast-cancer-pet-ct-imaging-with-68ga-pakti-29671https://curecurrent.com/trials/prevention-of-paclitaxel-induced-peripheral-neuropathy-in-breast-cancer-patients-29672https://curecurrent.com/trials/computerized-cognitive-training-in-breast-cancer-survivors-29673https://curecurrent.com/trials/cpap-for-motion-management-in-breast-radiotherapy-and-lung-liver-sabr-29674https://curecurrent.com/trials/laser-and-radiofrequency-for-treatment-of-vaginal-vulvar-atrophy-vva-in-women-treated-for-breast-cancer-epmlarf-arm2-29675https://curecurrent.com/trials/sabr-primer-evaluating-stereotactic-ablative-radiotherapy-for-primary-and-regional-breast-tumors-29676https://curecurrent.com/trials/young-empowered-strong-yes-the-young-women-s-breast-cancer-study-2-focus-on-intervention-pilot-29677https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-nal-iri-for-progressing-brain-metastases-in-breast-cancer-patients-29678https://curecurrent.com/trials/exemestane-letrozole-or-anastrozole-in-treating-postmenopausal-women-who-are-undergoing-surgery-for-stage-ii-or-stage-ii-29679https://curecurrent.com/trials/a-study-of-sirolimus-albumin-bound-in-combination-with-palbociclib-and-fulvestrant-for-the-treatment-of-advanced-breast-29680https://curecurrent.com/trials/optimal-optimisation-of-treatment-for-patients-with-low-stage-triple-negative-breast-cancer-with-high-stromal-tumor-infi-29681https://curecurrent.com/trials/chemotherapy-free-trastuzumab-and-pertuzumab-in-her2-positive-breast-cancer-fdg-pet-response-adapted-strategy-29682https://curecurrent.com/trials/clinical-efficacy-and-safety-assessment-of-breast-conserving-surgery-for-central-breast-cancer-a-prospective-randomized-29683https://curecurrent.com/trials/a-rollover-protocol-of-elacestrant-in-combination-with-onapristone-for-patients-with-er-pr-her2-advanced-or-metastatic-b-29684https://curecurrent.com/trials/toxicity-and-outcome-of-whole-breast-hypofractionated-radiotherapy-a-single-institution-experience-29685https://curecurrent.com/trials/development-and-application-of-accurate-detection-technology-based-on-multimodal-data-of-breast-cancer-comobid-depressio-29686https://curecurrent.com/trials/use-of-an-ultra-rapid-brca1-2-status-screening-test-in-diagnostic-and-theranostic-indication-performance-and-interest-fo-29687https://curecurrent.com/trials/a-safety-and-tolerability-study-of-nc762-in-subjects-with-advanced-or-metastatic-solid-tumors-29688https://curecurrent.com/trials/a-phase-study-of-hemay022-in-combination-with-ai-in-advanced-breast-cancer-29689https://curecurrent.com/trials/embr-wave-for-the-reduction-of-hot-flashes-in-women-with-a-history-of-breast-cancer-29690https://curecurrent.com/trials/study-to-compare-the-efficacy-and-safety-of-f-627-and-gran-29691https://curecurrent.com/trials/optimizing-extended-adjuvant-endocrine-therapy-in-patients-with-breast-cancer-29692https://curecurrent.com/trials/question-prompt-list-in-breast-cancer-patients-planned-for-neoadjuvant-chemotherapy-29693https://curecurrent.com/trials/the-sonimage-study-29694https://curecurrent.com/trials/improving-breast-health-knowledge-among-women-using-a-gamified-metaverse-based-platform-29695https://curecurrent.com/trials/improved-early-diagnosis-in-female-pelvic-cancer-with-oc-detect-29696https://curecurrent.com/trials/the-efficacy-of-oral-cryotherapy-in-preventing-trop2-adc-induced-oral-mucositis-in-patients-with-advanced-breast-cancer-29697https://curecurrent.com/trials/eligibility-screening-for-the-nih-intramural-research-program-clinical-protocols-29698https://curecurrent.com/trials/adjuvant-chemoradiation-and-biomarkers-of-response-in-high-risk-breast-cancer-29699https://curecurrent.com/trials/window-of-opportunity-trial-of-neoadjuvant-olaparib-and-durvalumab-for-triple-negative-or-low-er-breast-cancer-29700https://curecurrent.com/trials/pet-in-breast-cancer-receiving-neoadjuvant-chemotherapy-29701https://curecurrent.com/trials/oncological-safety-of-oncoplastic-breast-surgery-in-multicentric-breast-cancer-29702https://curecurrent.com/trials/one-day-mind-programme-for-women-with-breast-cancer-29703https://curecurrent.com/trials/ways-of-retaining-the-inframammary-fold-in-implant-based-breast-surgery-29704https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-fulvestrant-plus-dna-damage-repair-inhibitors-after-a-cdk4-6-inhibitor-29705https://curecurrent.com/trials/talazoparib-in-advanced-breast-cancer-patients-with-homologous-recombinant-deficiency-29706https://curecurrent.com/trials/a-study-of-bdtx-189-an-orally-available-allosteric-erbb-inhibitor-in-patients-with-advanced-solid-tumors-29707https://curecurrent.com/trials/pemvin-vs-vin-in-previously-treated-metastatic-breast-cancer-29708https://curecurrent.com/trials/molecular-profiling-in-young-50-years-of-age-patients-with-metastatic-breast-cancer-29709https://curecurrent.com/trials/lung-and-breast-cancer-prevention-by-an-integrated-intervention-of-maternal-smoking-cessation-and-breastfeeding-29710https://curecurrent.com/trials/sirolimus-for-injection-albumin-bound-combined-with-fulvestrant-for-hr-her2-advanced-metastatic-breast-cancer-patients-p-29711https://curecurrent.com/trials/a-dose-image-optimization-trial-evaluating-mannitol-and-voluven-as-adjuncts-for-indocyanine-green-29712https://curecurrent.com/trials/improvement-in-breast-skin-sensibility-after-breast-reconstruction-a-comparison-of-3-surgical-techniques-29713https://curecurrent.com/trials/at-home-breast-oncology-care-delivered-with-e-health-solutions-29714https://curecurrent.com/trials/th1902-in-patients-with-advanced-solid-tumors-29715https://curecurrent.com/trials/study-of-b013-and-nab-paclitaxel-for-locally-advanced-or-metastatic-triple-negative-breast-cancer-29716https://curecurrent.com/trials/impact-of-targeted-nutritional-apport-and-exercise-on-the-modulation-of-metabolic-and-immune-related-gene-expression-sig-29717https://curecurrent.com/trials/veliparib-and-irinotecan-hydrochloride-in-treating-patients-with-cancer-that-is-metastatic-or-cannot-be-removed-by-surge-29718https://curecurrent.com/trials/postoperative-radiotherapy-in-breast-cancer-concurrent-or-sequential-with-chemotherapy-29719https://curecurrent.com/trials/impact-of-bmi-on-cdk4-6-inhibitors-efficacy-and-safety-in-advanced-breast-cancer-29720https://curecurrent.com/trials/corneal-changes-in-estrogen-dependent-breast-cancer-after-hormonal-treatment-29721https://curecurrent.com/trials/study-to-assess-the-safety-and-tolerability-of-a-parp-inhibitor-in-combination-with-carboplatin-and-or-paclitaxel-29722https://curecurrent.com/trials/subpectoral-plexus-block-with-multi-level-tpvb-for-surgical-anesthesia-during-primary-breast-cancer-surgery-29723https://curecurrent.com/trials/sensory-restoration-after-diep-flap-neurotization-29724https://curecurrent.com/trials/viscum-album-for-tnbc-on-adjuvant-pembrolizumab-29725https://curecurrent.com/trials/trial-evaluating-role-of-post-mastectomy-radiotherapy-in-women-with-node-negative-early-breast-cancer-29726https://curecurrent.com/trials/metastatic-breast-cancer-in-austria-29727https://curecurrent.com/trials/assessment-of-the-breast-cosmesis-using-deep-neural-networks-an-exploratory-study-abcd-29728https://curecurrent.com/trials/postoperative-opt-in-narcotics-treatment-in-breast-29729https://curecurrent.com/trials/patient-satisfaction-survey-pss-in-breast-clinic-29730https://curecurrent.com/trials/biology-guided-therapy-for-breast-cancer-for-er-positive-29731https://curecurrent.com/trials/genomic-testing-and-resulting-medical-decisions-29732https://curecurrent.com/trials/longitudinal-ctdna-surveillance-for-older-women-with-er-breast-cancer-who-omit-surgery-29733https://curecurrent.com/trials/study-of-ob-002-in-patients-with-refractory-metastatic-cancer-29734https://curecurrent.com/trials/phase-iii-trial-evaluating-radium-bromatum-homeopathic-treatment-efficacy-on-radiodermatitis-prevention-and-treatment-fo-29735https://curecurrent.com/trials/timing-of-specific-exercise-therapy-after-breast-cancer-surgery-early-versus-delayed-initiation-29736https://curecurrent.com/trials/observational-clinical-study-on-role-of-mrd-in-predicting-local-therapy-in-oligometastatic-breast-cancer-29737https://curecurrent.com/trials/trace4bus-for-bi-rads-classification-29738https://curecurrent.com/trials/pre-operative-trastuzumab-in-operable-breast-cancer-29739https://curecurrent.com/trials/cardiac-rehabilitation-to-improve-breast-cancer-outcomes-29740https://curecurrent.com/trials/pioglitazone-therapy-targeting-fatigue-in-breast-cancer-29741https://curecurrent.com/trials/adapt-adjuvant-dynamic-marker-adjusted-personalized-therapy-trial-optimizing-risk-assessment-and-therapy-response-predic-29742https://curecurrent.com/trials/imaging-versus-cardiac-biomarker-monitored-her2-directed-therapy-in-patients-with-breast-cancer-29743https://curecurrent.com/trials/awareness-based-stress-reduction-program-applied-to-breast-cancer-patients-receiving-chemotherapy-29744https://curecurrent.com/trials/evaluation-of-radiobiological-effects-in-skin-toxicities-for-breast-cancer-patients-with-pencil-beam-scanning-proton-the-29745https://curecurrent.com/trials/safety-of-continuing-her-2-directed-therapy-in-overt-left-ventricular-dysfunction-29746https://curecurrent.com/trials/study-to-assess-the-ability-of-the-portable-scalp-cooling-system-pscs-to-prevent-hair-loss-29747https://curecurrent.com/trials/preoperative-vs-pathologic-size-in-breast-cancer-a-prospective-study-29748https://curecurrent.com/trials/exbrac-the-pilot-study-29749https://curecurrent.com/trials/vaccine-therapy-with-sargramostim-gm-csf-in-treating-patients-with-her-2-positive-stage-iii-iv-breast-cancer-or-ovarian-29750https://curecurrent.com/trials/long-term-multidisciplinary-physiotherapy-for-breast-cancer-survivors-a-randomized-controlled-trial-29751https://curecurrent.com/trials/phase-1-trial-of-sync-t-immunotherapy-for-patients-with-advanced-metastatic-solid-tumors-29752https://curecurrent.com/trials/acupuncture-treatment-of-chemotherapy-induced-peripheral-neuropathy-in-women-29753https://curecurrent.com/trials/breast-mri-as-a-preoperative-tool-for-dcis-29754https://curecurrent.com/trials/the-effect-of-roy-adaptation-model-based-nursing-interventions-on-psychological-resilience-and-psychosocial-adjustment-i-29755https://curecurrent.com/trials/reducing-pain-and-disability-after-breast-cancer-surgery-29756https://curecurrent.com/trials/evaluation-of-the-feasibility-of-a-study-comparing-local-anesthesia-and-general-anesthesia-in-conservative-surgery-for-b-29757https://curecurrent.com/trials/cognitive-training-and-brain-stimulation-in-women-with-post-chemotherapy-cognitive-impairment-29758https://curecurrent.com/trials/a-feasibility-study-of-topical-cannabinoids-for-treatment-of-aromatase-inhibitor-associated-musculoskeletal-syndrome-aim-29759https://curecurrent.com/trials/application-of-endoscell-intraoperative-cellular-probing-technology-for-early-stage-breast-cancer-29760https://curecurrent.com/trials/study-of-xb002-in-subjects-with-solid-tumors-jewel-101-29761https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-enzalutamide-with-trastuzumab-in-patients-with-human-epidermal-growth-facto-29762https://curecurrent.com/trials/incmga00012-and-pelareorep-for-the-treatment-of-metastatic-triple-negative-breast-cancer-irene-study-29763https://curecurrent.com/trials/the-effect-of-hyperbaric-oxygen-therapy-on-breast-cancer-patients-with-late-radiation-toxicity-umbrella-honey-trial-29764https://curecurrent.com/trials/effect-of-anthracyclines-and-cyclophosphamide-on-cardiovascular-responses-29765https://curecurrent.com/trials/personal-sleep-in-breast-cancer-29766https://curecurrent.com/trials/photoacoustic-ultrasound-imaging-for-breast-nodule-diagnosis-molecular-classification-and-neoadjuvant-chemotherapy-respo-29767https://curecurrent.com/trials/study-of-seribantumab-in-adult-patients-with-nrg1-gene-fusion-positive-advanced-solid-tumors-29768https://curecurrent.com/trials/study-to-investigate-the-chemotherapy-induced-peripheral-neuropathy-cipn-onset-suppressing-effect-and-safety-of-ono-2910-29769https://curecurrent.com/trials/accelerated-partial-breast-irradiation-using-external-beam-volumetric-modulated-arc-therapy-vmat-a-randomised-non-inferi-29770https://curecurrent.com/trials/bortezomib-plus-cisplatin-in-recurrent-or-metastatic-breast-cancer-29771https://curecurrent.com/trials/improving-patient-centered-communication-in-breast-cancer-through-patient-and-provider-interventions-29772https://curecurrent.com/trials/electroacupuncture-for-the-prevention-of-chemotherapy-induced-nausea-and-vomiting-in-patients-with-breast-cancer-29773https://curecurrent.com/trials/a-phase-1-2-open-label-multi-center-study-of-the-safety-and-efficacy-of-alomfilimab-ky1044-as-single-agent-and-in-combin-29774https://curecurrent.com/trials/prepectoral-and-subpectoral-implant-based-breast-reconstruction-29775https://curecurrent.com/trials/nurse-led-proactive-telephone-follow-up-with-patients-after-completion-of-primary-cancer-treatment-29776https://curecurrent.com/trials/accelerated-partial-breast-irradiation-study-29777https://curecurrent.com/trials/analysis-of-circulating-tumor-markers-in-blood-29778https://curecurrent.com/trials/the-immune-response-of-breast-cancer-patients-treated-with-levobupivacaine-using-paravertebral-or-superficial-chest-bloc-29779https://curecurrent.com/trials/study-of-lipid-mediators-in-chronic-postoperative-pain-licp-29780https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-neoadjuvant-treatment-based-on-dual-blockade-with-pertuzumab-and-the-trastu-29781https://curecurrent.com/trials/capivasertib-plus-fulvestrant-vs-fulvestrant-in-primary-high-risk-lobular-breast-cancer-29782https://curecurrent.com/trials/predictive-role-of-new-biomarkers-for-hypersensitive-patients-to-radiation-in-breast-cancer-biorise-29783https://curecurrent.com/trials/spsipb-for-breast-cancer-surgery-29784https://curecurrent.com/trials/dzd1516-in-combination-with-trastuzumab-and-capecitabine-or-in-combination-with-t-dm1-in-patients-with-metastatic-her2-p-29785https://curecurrent.com/trials/three-antidiarrheal-strategies-in-her2-hr-early-breast-cancer-patients-treated-with-extended-adjuvant-neratinib-29786https://curecurrent.com/trials/breast-cancer-survivor-educational-intervention-29787https://curecurrent.com/trials/impact-of-home-based-aerobic-and-strength-exercises-during-chemotherapy-for-early-breast-cancer-on-biomarkers-of-aging-29788https://curecurrent.com/trials/a-new-cancer-rehabilitation-process-for-chemotherapy-induced-foot-neuropathy-using-orthopedic-devices-29789https://curecurrent.com/trials/her2-human-epidermal-growth-factor-receptor-2-positive-metastatic-breast-cancer-in-russia-29790https://curecurrent.com/trials/a-phase-ii-single-arm-clinical-study-to-explore-the-efficacy-and-safety-of-hyperbaric-oxygen-in-the-neoadjuvant-treatmen-29791https://curecurrent.com/trials/her2-imaging-study-to-identify-her2-positive-metastatic-breast-cancer-patient-unlikely-to-benefit-from-t-dm1-29792https://curecurrent.com/trials/using-luminomark-vs-coventional-practice-for-targeted-axillary-surgery-29793https://curecurrent.com/trials/using-hyperpolarized-1-13c-pyruvate-to-detect-cardiotoxicity-29794https://curecurrent.com/trials/breast-screening-risk-adaptive-imaging-for-density-29795https://curecurrent.com/trials/establishment-and-clinical-application-of-breast-cancer-risk-prediction-model-based-on-traditional-chinese-medicine-four-29796https://curecurrent.com/trials/prospective-phase-ii-study-of-intraoperative-radiotherapy-iort-in-elderly-patients-with-small-breast-cancer-29797https://curecurrent.com/trials/feasibility-of-implementing-acupuncture-into-federally-qualified-health-center-among-breast-cancer-survivors-29798https://curecurrent.com/trials/whole-body-mri-in-oncology-29799https://curecurrent.com/trials/trimetazidine-efficacy-in-attenuating-paclitaxel-induced-peripheral-neuropathy-29800https://curecurrent.com/trials/identification-and-validation-of-biomarkers-for-breast-cancer-resistance-protein-bcrp-29801https://curecurrent.com/trials/comparison-of-whole-breast-screening-ultrasound-and-contrast-enhanced-mammography-for-supplemental-breast-cancer-screeni-29802https://curecurrent.com/trials/visr-for-noninvasively-interrogating-stromal-collagen-organization-as-a-breast-cancer-biomarker-evaluation-of-compressio-29803https://curecurrent.com/trials/chronic-pain-in-post-mastectomy-patients-the-difference-between-pectoral-nerve-pecs-i-ii-and-erector-spinal-plane-esp-bl-29804https://curecurrent.com/trials/in-our-study-we-compare-results-of-two-oncoplastic-breast-surgery-short-scar-reduction-mammoplasty-and-wise-pattern-redu-29805https://curecurrent.com/trials/sentinel-node-localization-and-staging-with-low-dose-superparamagnetic-iron-oxide-29806https://curecurrent.com/trials/postoperative-identification-of-tumor-cells-at-the-lumpectomy-site-of-patients-with-early-breast-cancer-29807https://curecurrent.com/trials/tucatinib-in-combination-with-oral-etoposide-andtrastuzumab-in-patients-with-metastatic-her2-breast-cancer-29808https://curecurrent.com/trials/a-study-of-tas-120-in-patients-with-advanced-solid-tumors-29809https://curecurrent.com/trials/effect-of-audiovisual-education-on-breast-cancer-29810https://curecurrent.com/trials/omission-of-radiation-in-patients-with-her-2-positive-breast-cancer-29811https://curecurrent.com/trials/cancer-surveillance-and-support-29812https://curecurrent.com/trials/axillary-staging-in-early-breast-cancer-snb-vs-pet-mri-29813https://curecurrent.com/trials/descartes-de-escalation-of-radiotherapy-in-patients-with-pathologic-complete-response-to-neoadjuvant-systemic-therapy-29814https://curecurrent.com/trials/compare-analgesia-between-mtp-block-and-espb-in-mrm-29815https://curecurrent.com/trials/impact-of-perioperative-nutrition-intervention-on-bioimpedance-phase-angle-ipenipa-in-breast-cancer-patients-29816https://curecurrent.com/trials/improving-response-to-chemotherapy-by-adding-physical-exercise-in-the-neoadjuvant-setting-of-breast-cancer-patients-29817https://curecurrent.com/trials/targit-c-consolidation-prospective-phase-iv-study-of-iort-in-patients-with-small-breast-cancer-29818https://curecurrent.com/trials/a-study-of-shr-a1811-and-fulvestrant-with-or-without-hs-10352-in-locally-advanced-or-metastatic-breast-cancer-patients-29819https://curecurrent.com/trials/a-trial-of-camrelizumab-plus-nab-paclitaxel-and-levocetirizine-in-metastatic-or-recurrent-tnbc-29820https://curecurrent.com/trials/carboplatin-intensified-chemotherapy-for-triple-negative-breast-cancer-citrine-29821https://curecurrent.com/trials/health-coaching-based-navigation-at-the-conclusion-of-treatment-for-the-support-of-black-breast-cancer-survivors-29822https://curecurrent.com/trials/evolution-of-neoadjuvant-treatment-in-triple-negative-or-her-2-positive-breast-cancer-diagnosed-in-the-early-phase-29823https://curecurrent.com/trials/the-effect-of-the-quran-on-quality-of-life-and-quality-of-sleep-in-breast-cancer-29824https://curecurrent.com/trials/a-multicenter-prospective-cohort-study-of-trop-2-adc-combination-therapy-for-advanced-triple-negative-breast-cancer-29825https://curecurrent.com/trials/palbociclib-and-binimetinib-in-advanced-triple-negative-breast-cancer-29826https://curecurrent.com/trials/radiotherapy-with-immunotherapy-and-anti-angiogenic-therapy-for-advanced-her2-negative-breast-cancer-a-single-arm-study-29827https://curecurrent.com/trials/jskn003-versus-trastuzumab-emtansine-t-dm1-for-her2-positive-advanced-breast-cancer-29828https://curecurrent.com/trials/a-phase-ii-study-of-chiauranib-in-combine-with-capecitabine-in-tnbc-29829https://curecurrent.com/trials/21-gene-in-elder-breast-cancer-patients-with-lymph-node-metastasis-29830https://curecurrent.com/trials/oral-stat3-inhibitor-tti-101-in-patients-with-advanced-cancers-29831https://curecurrent.com/trials/chemotherapy-and-lapatinib-or-trastuzumab-in-treating-women-with-her2-neu-positive-metastatic-breast-cancer-29832https://curecurrent.com/trials/cardiovascular-prevention-strategies-in-elderly-patients-with-cancer-cartier-clinical-trial-29833https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-nanosomal-docetaxel-lipid-suspension-in-triple-negative-breast-cancer-pat-29834https://curecurrent.com/trials/psychoneurological-symptom-cluster-in-oncology-29835https://curecurrent.com/trials/a-randomized-multicenter-pragmatic-trial-comparing-bone-pain-from-a-single-dose-of-pegfilgrastim-to-5-doses-of-daily-fil-29836https://curecurrent.com/trials/a-novel-approach-for-alleviating-the-side-effects-of-chemotherapeutic-agents-29837https://curecurrent.com/trials/expanded-access-protocol-for-subjects-previously-treated-with-gedatolisib-in-b2151009-29838https://curecurrent.com/trials/efficacy-of-tislelizumab-and-spartalizumab-across-multiple-cancer-types-in-patients-with-pd1-high-mrna-expressing-tumors-29839https://curecurrent.com/trials/case-control-study-to-identify-modifiable-risk-factors-for-colorectal-and-breast-cancer-in-nigeria-29840https://curecurrent.com/trials/altto-adjuvant-lapatinib-and-or-trastuzumab-treatment-optimisation-study-big-2-06-n063d-29841https://curecurrent.com/trials/genomics-guided-targeted-post-neoadjuvant-therapy-in-patients-with-early-breast-cancer-cognition-guide-29842https://curecurrent.com/trials/analysis-of-exploring-optimized-sequential-treatment-strategies-of-antibody-drug-conjugates-adcs-in-her2-low-expressing-29843https://curecurrent.com/trials/first-in-human-study-of-mattisse-tissue-engineering-chamber-in-adult-female-patients-undergoing-breast-reconstruction-af-29844https://curecurrent.com/trials/locoregional-control-with-radiotherapy-of-breast-cancer-patients-with-macrometastases-treated-with-mastectomy-macma-29845https://curecurrent.com/trials/novel-neoadjuvant-and-adjuvant-strategy-for-germline-brca-1-2-mutated-triple-negative-breast-cancer-29846https://curecurrent.com/trials/the-effect-of-bse-training-on-breast-cancer-knowledge-level-and-health-beliefs-29847https://curecurrent.com/trials/the-effect-of-web-based-breast-self-examination-education-29848https://curecurrent.com/trials/circadian-rhythm-impact-on-tnbc-response-to-neoadjuvant-immunotherapy-29849https://curecurrent.com/trials/application-of-patient-blood-management-in-the-oncology-patient-affected-by-breast-cancer-29850https://curecurrent.com/trials/the-effect-of-a-multi-modal-program-on-fear-of-cancer-recurrence-in-breast-cancer-patients-29851https://curecurrent.com/trials/clinical-trial-of-sys6010-syh2051-versus-chemotherapy-in-advanced-breast-cancer-and-other-solid-tumors-29852https://curecurrent.com/trials/women-s-interventions-for-sexual-health-wish-29853https://curecurrent.com/trials/a-post-marketing-surveillance-to-assess-the-safety-and-effectiveness-of-zirabev-in-domestic-patients-with-various-cancer-29854https://curecurrent.com/trials/universal-genetic-testing-versus-guidelines-directed-testing-for-germline-pathogenic-variants-among-non-western-patients-29855https://curecurrent.com/trials/a-study-assessing-risk-factors-for-oral-mucositis-stomatitis-and-ocular-surface-events-in-nsclc-and-breast-cancer-29856https://curecurrent.com/trials/comparison-of-clinical-efficacy-between-letrozole-ribociclib-and-fulvestrant-letrozole-ribociclib-in-hormone-receptor-po-29857https://curecurrent.com/trials/high-resolution-3d-diffusion-weighted-breast-mri-29858https://curecurrent.com/trials/real-world-study-on-shenbailing-granules-for-improving-qi-and-blood-deficiency-in-patients-after-breast-cancer-surgery-29859https://curecurrent.com/trials/cardiac-rehabilitation-program-on-the-prevention-of-cardiotoxicity-in-breast-cancer-patients-undergoing-treatment-with-a-29860https://curecurrent.com/trials/the-efficacy-and-safety-of-cdk4-6-inhibitors-in-combination-with-endocrine-therapy-in-the-neoadjuvant-treatment-29861https://curecurrent.com/trials/investigating-the-effects-of-different-incision-types-on-aesthetic-outcomes-and-incision-related-complications-after-bre-29862https://curecurrent.com/trials/a-phase-1-2-study-of-vio-01-in-participants-with-recurrent-solid-tumors-29863https://curecurrent.com/trials/the-benefits-of-continued-use-of-ovarian-function-suppression-after-5-years-29864https://curecurrent.com/trials/neoadjuvant-radiotherapy-and-immediate-implant-based-breast-reconstruction-29865https://curecurrent.com/trials/margetuximab-plus-chemotherapy-vs-trastuzumab-plus-chemotherapy-in-the-treatment-of-her2-metastatic-breast-cancer-29866https://curecurrent.com/trials/intervention-to-promote-breast-cancer-screening-among-american-indian-women-29867https://curecurrent.com/trials/a-trial-of-hrs-1358-tablets-in-metastatic-or-local-advanced-breast-cancer-29868https://curecurrent.com/trials/ultrahypofractionated-whole-breast-radiation-following-chemotherapy-29869https://curecurrent.com/trials/a-multi-mode-thermophysical-immunotherapy-study-for-breast-cancer-liver-metastases-29870https://curecurrent.com/trials/application-of-cfdna-methylation-detection-in-auxiliary-diagnosis-of-breast-cancer-29871https://curecurrent.com/trials/lymphovenous-anastomosis-for-breast-cancer-lymphedema-29872https://curecurrent.com/trials/effect-of-an-amino-acids-and-flavonoids-containing-fsmp-on-chemotherapy-toxicity-nutritional-status-and-quality-of-life-29873https://curecurrent.com/trials/abt-888-and-temozolomide-for-metastatic-breast-cancer-and-brca1-2-breast-cancer-29874https://curecurrent.com/trials/sacubitril-valsartan-in-primary-prevention-of-the-cardiotoxicity-of-systematic-breast-cancer-treatment-mainstream-29875https://curecurrent.com/trials/development-of-a-blood-test-to-improve-the-performance-of-breast-cancer-screening-29876https://curecurrent.com/trials/mental-health-disparities-in-spanish-speaking-latina-breast-cancer-patients-29877https://curecurrent.com/trials/real-world-study-of-bone-metastases-in-patients-with-advanced-breast-cancer-29878https://curecurrent.com/trials/transgender-and-gender-diverse-individuals-screening-for-breast-cancer-29879https://curecurrent.com/trials/phase-2-study-of-the-monoclonal-antibody-mgah22-margetuximab-in-patients-with-relapsed-or-refractory-advanced-breast-can-29880https://curecurrent.com/trials/surgical-outcome-of-bcs-using-icg-f-in-breast-cancer-patients-after-preoperative-chemotherapy-29881https://curecurrent.com/trials/clinical-application-of-multi-modal-sentinel-lymph-node-staining-method-in-breast-cancer-patients-after-neoadjuvant-chem-29882https://curecurrent.com/trials/observational-retrospective-and-prospective-non-interventional-multicentre-on-the-use-of-genomic-testing-in-the-manageme-29883https://curecurrent.com/trials/digital-phenotyping-in-young-breast-cancer-patients-treated-with-neoadjuvant-chemotherapy-29884https://curecurrent.com/trials/the-relationship-between-the-density-of-cancer-associated-fibroblasts-in-the-peritumoral-stroma-and-clinicopathological-29885https://curecurrent.com/trials/comparison-of-erector-spinae-plane-block-and-serratus-posterior-superior-intercostal-plane-block-29886https://curecurrent.com/trials/breast-cancer-and-resilience-in-couple-29887https://curecurrent.com/trials/a-multicenter-cancer-biospecimen-collection-study-29888https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-and-chemotherapy-neoadjuvant-therapy-for-her2-positive-breast-cancer-29889https://curecurrent.com/trials/neoadjuvant-carboplatin-and-docetaxel-in-triple-negative-breast-cancer-29890https://curecurrent.com/trials/use-of-machine-learning-techniques-for-serial-assessment-of-systemic-inflammatory-markers-in-breast-cancer-patients-29891https://curecurrent.com/trials/a-clinical-study-to-determine-the-pharmacokinetics-of-oraxol-in-breast-cancer-patients-29892https://curecurrent.com/trials/extension-study-of-lapatinib-plus-herceptin-with-or-without-endocrine-therapy-29893https://curecurrent.com/trials/a-phase-i-ii-study-of-fragmented-autoantigen-stimulated-t-cell-immunotherapy-combined-with-radiotherapy-fast-cr-29894https://curecurrent.com/trials/effectiveness-of-community-health-workers-in-breast-cancer-prevention-in-jumla-a-cluster-randomized-trials-29895https://curecurrent.com/trials/evaluation-of-changes-in-the-immunological-microenvironment-surrounding-subcutaneous-breast-cancer-metastases-after-liqu-29896https://curecurrent.com/trials/a-study-of-pm8002-plus-nab-paclitaxel-as-first-line-therapy-for-tnbc-29897https://curecurrent.com/trials/lymphbridge-surgical-evaluation-for-breast-cancer-associated-lymphedema-biobridge-29898https://curecurrent.com/trials/predictive-value-of-tumor-vascular-normalization-scoring-in-her-2-positive-breast-cancer-29899https://curecurrent.com/trials/randomized-controlled-clinical-study-of-efficacy-and-safety-of-initumab-combined-with-pyrrotinib-and-chemotherapeutic-ag-29900https://curecurrent.com/trials/implementation-effectiveness-and-impact-of-a-value-based-intervention-for-patients-with-breast-or-lung-cancer-29901https://curecurrent.com/trials/the-study-is-observational-and-retrospective-lifestyle-bmi-and-activity-physical-29902https://curecurrent.com/trials/pakt-azd5363-in-combination-with-paclitaxel-in-triple-negative-advanced-or-metastatic-breast-cancer-29903https://curecurrent.com/trials/fatigue-as-a-late-effect-in-breast-cancer-survivors-is-acupuncture-a-treatment-option-29904https://curecurrent.com/trials/the-efficacy-of-tianeptine-versus-pregabalin-on-acute-and-chronic-post-mastectomy-pain-after-breast-cancer-surgery-29905https://curecurrent.com/trials/prospective-multicentre-phase-iv-clinical-trial-of-olaparib-in-indian-patients-with-ovarian-and-metastatic-breast-cancer-29906https://curecurrent.com/trials/a-study-of-tbio-4101-til-and-pembrolizumab-in-patients-with-advanced-solid-tumors-29907https://curecurrent.com/trials/the-effect-of-breathing-exercise-on-sleep-and-stress-levels-in-women-with-breast-cancer-receiving-chemotherapy-treatment-29908https://curecurrent.com/trials/examining-the-effectiveness-of-multidisciplinary-care-teams-in-improving-outcomes-for-breast-cancer-patients-29909https://curecurrent.com/trials/assessment-of-cancer-related-brain-fog-using-the-test-of-strategic-learning-29910https://curecurrent.com/trials/comparing-the-efficacy-of-nab-ph-pyrrolitinib-and-tcbhp-in-the-neoadjuvant-treatment-of-her2-positive-bc-29911https://curecurrent.com/trials/study-of-efficacy-and-safety-of-lee011-in-postmenopausal-women-with-advanced-breast-cancer-29912https://curecurrent.com/trials/low-dose-tamoxifen-for-mammographic-density-reduction-29913https://curecurrent.com/trials/a-study-to-compare-the-safety-and-efficacy-of-an-aromatase-inhibitor-in-combination-with-lapatinib-trastuzumab-or-both-f-29914https://curecurrent.com/trials/adaptive-nutrition-and-exercise-weight-loss-a-new-study-29915https://curecurrent.com/trials/prospective-registry-of-advanced-stage-cancer-prefer-patients-to-assess-prevalence-of-actionable-biomarkers-and-driver-m-29916https://curecurrent.com/trials/radiation-therapy-during-surgery-in-treating-older-women-with-stage-i-breast-cancer-29917https://curecurrent.com/trials/effect-of-positive-end-expiratory-pressure-on-the-gastric-volume-29918https://curecurrent.com/trials/comparison-of-full-field-digital-mammography-with-digital-breast-tomography-for-screening-call-back-rates-29919https://curecurrent.com/trials/robotic-nipple-sparing-mastectomy-with-immediate-reconstruction-29920https://curecurrent.com/trials/lol-it-s-all-improv-after-cancer-29921https://curecurrent.com/trials/disitamab-vedotin-in-combination-with-metronomic-chemotherapy-in-advanced-her2-expressing-breast-cancer-29922https://curecurrent.com/trials/efficacy-and-safety-of-biweekly-regimen-of-eribulin-versus-a-standard-regimen-for-the-treatment-of-locally-recurrent-or-29923https://curecurrent.com/trials/evaluation-of-somatostatin-receptor-expression-in-pet-68ga-dotatoc-in-patients-followed-for-metastatic-breast-cancer-29924https://curecurrent.com/trials/effect-of-neoadjuvant-chemotherapy-on-cardiac-function-of-perioperative-patients-with-breast-cancer-and-new-strategies-f-29925https://curecurrent.com/trials/a-study-of-sirolimus-albumin-bound-in-combination-with-palbociclib-and-fulvestrant-for-the-treatment-of-advanced-breast-29926https://curecurrent.com/trials/the-added-value-of-dbt-over-mammography-in-local-tumor-staging-in-patients-with-birads-4-or-5-lesions-29927https://curecurrent.com/trials/clinical-exploratory-study-on-predicting-drug-sensitivity-for-breast-cancer-treatment-using-simulated-organoid-models-29928https://curecurrent.com/trials/taek-vac-herby-vaccine-for-brachyury-and-her2-expressing-cancer-29929https://curecurrent.com/trials/seroma-of-the-mammary-gland-29930https://curecurrent.com/trials/probability-of-oncotypedx-to-reallocate-as-low-or-high-risk-of-recurrence-breast-cancer-patients-with-uncertain-biology-29931https://curecurrent.com/trials/the-clinical-study-of-the-efficacy-and-safety-of-trop2-adc-monotherapy-or-combination-immunotherapy-strategy-in-the-trea-29932https://curecurrent.com/trials/functional-selection-of-advanced-breast-cancer-patients-for-talazoparib-treatment-using-the-repair-capacity-recap-test-29933https://curecurrent.com/trials/spect-analysis-of-cardiac-perfusion-changes-after-whole-breast-chest-wall-radiation-therapy-with-abc-29934https://curecurrent.com/trials/evaluation-of-the-restart-survival-programme-29935https://curecurrent.com/trials/specimen-and-data-study-for-ovarian-cancer-early-detection-and-prevention-29936https://curecurrent.com/trials/adjuvant-dynamic-marker-adjusted-personalized-therapy-trial-optimizing-risk-assessment-and-therapy-response-prediction-i-29937https://curecurrent.com/trials/simvastatin-plus-dual-anti-her2-therapy-for-metastatic-breast-cancer-29938https://curecurrent.com/trials/correlation-of-clinical-response-to-pathologic-response-in-patients-with-early-breast-cancer-29939https://curecurrent.com/trials/adjuvant-dynamic-marker-adjusted-personalized-therapy-trial-optimizing-risk-assessment-and-therapy-response-prediction-i-29940https://curecurrent.com/trials/meridian-yoga-on-chemotherapy-induced-peripheral-neuropathy-in-breast-cancer-patients-29941https://curecurrent.com/trials/financial-navigation-program-for-improving-financial-toxicity-among-breast-cancer-in-china-29942https://curecurrent.com/trials/cmp-001-and-pre-operative-stereotactic-body-radiation-therapy-sbrt-in-early-stage-triple-negative-breast-cancer-tnbc-29943https://curecurrent.com/trials/him-typing-guides-the-treatment-of-advanced-first-line-triple-negative-breast-cancer-29944https://curecurrent.com/trials/mind-over-matter-for-black-and-african-american-women-a-single-arm-trial-examining-feasibility-and-acceptability-of-a-su-29945https://curecurrent.com/trials/evaluation-of-the-functional-emotional-life-characteristics-of-ongoing-eat-in-bc-patients-with-reduced-bmd-29946https://curecurrent.com/trials/a-prospective-randomized-multicenter-open-label-comparison-of-preoperative-trastuzumab-emtansine-t-dm1-with-or-without-s-29947https://curecurrent.com/trials/a-prospective-multicenter-open-label-12-week-neoadjuvant-phase-ii-trial-optimizing-taxane-therapy-in-elderly-patients-wi-29948https://curecurrent.com/trials/a-prospective-randomized-multicenter-open-label-comparison-of-preoperative-combination-of-trastuzumab-and-pertuzumab-wit-29949https://curecurrent.com/trials/icg-fluorescence-imaging-for-intraoperative-breast-cancer-margins-evaluation-a-dose-timing-study-29950https://curecurrent.com/trials/phase-i-ii-clinical-study-of-taurine-for-external-use-in-the-prevention-and-treatment-of-acute-radiation-skin-injury-29951https://curecurrent.com/trials/design-and-evaluation-of-the-effects-of-a-physical-therapy-program-with-digital-support-in-patients-with-breast-cancer-29952https://curecurrent.com/trials/the-burnalong-pilot-study-for-adolescent-and-young-adult-cancer-survivors-29953https://curecurrent.com/trials/study-on-the-progress-of-breast-cancer-cases-in-males-and-the-assessment-of-relapse-risk-29954https://curecurrent.com/trials/second-look-ultrasound-post-contrast-enhanced-mammography-for-additional-lesions-characterization-29955https://curecurrent.com/trials/safety-study-of-mgah22-in-her2-positive-carcinomas-29956https://curecurrent.com/trials/facile-feasibility-of-first-line-ribociclib-in-older-patients-with-advanced-breast-cancer-29957https://curecurrent.com/trials/iit2020-20-shirazip-walk-nature-walks-29958https://curecurrent.com/trials/multicenter-hologic-tomosynthesis-study-29959https://curecurrent.com/trials/sexual-coercion-in-breast-cancer-patients-treated-with-luteinizing-hormone-releasing-hormone-agonists-lhrha-29960https://curecurrent.com/trials/trial-of-h3b-6545-in-women-with-locally-advanced-or-metastatic-estrogen-receptor-positive-her2-negative-breast-cancer-29961https://curecurrent.com/trials/nipple-aspirate-fluid-in-detecting-breast-cancer-29962https://curecurrent.com/trials/contrast-enhanced-mammography-or-breast-magnetic-resonance-which-choice-for-optimal-diagnostic-performance-29963https://curecurrent.com/trials/contrast-enhanced-mammography-in-the-evaluation-of-cancer-of-unknown-primary-syndrome-29964https://curecurrent.com/trials/pd-l1-inhibitor-rt-ursodeoxycholic-acid-in-recurrent-metastatic-her2-neg-breast-cancer-29965https://curecurrent.com/trials/marker-technique-comparison-in-targeted-axillary-dissection-29966https://curecurrent.com/trials/the-xenera-1-study-tests-xentuzumab-in-combination-with-everolimus-and-exemestane-in-women-with-hormone-receptor-positiv-29967https://curecurrent.com/trials/tranexamic-acid-usage-in-bilateral-mastectomy-to-reduce-post-surgical-drainage-29968https://curecurrent.com/trials/quilt-3-049-nant-triple-negative-breast-cancer-tnbc-vaccine-combination-immunotherapy-in-subjects-with-tnbc-who-have-pro-29969https://curecurrent.com/trials/inspire-a-multi-cancer-early-detection-study-29970https://curecurrent.com/trials/quilt-3-057-nant-neoadjuvant-triple-negative-breast-cancer-tnbc-vaccine-29971https://curecurrent.com/trials/targeted-axillary-dissection-tad-in-early-stage-node-positive-breast-cancer-29972https://curecurrent.com/trials/study-of-palliative-radiation-combined-with-pembrolizumab-in-unresectable-metastatic-stage-iv-breast-cancer-29973https://curecurrent.com/trials/feasibility-of-a-preoperative-multimodal-lifestyle-intervention-in-patients-with-breastcancer-29974https://curecurrent.com/trials/dwi-breast-mri-in-dense-breast-a-clinical-trial-to-assess-the-efficacy-and-diagnostic-accuracy-of-diffusion-weighted-ima-29975https://curecurrent.com/trials/neoadjuvant-treatment-of-triple-negative-breast-cancer-with-stereotactic-radiotherapy-pd-1-monoclonal-antibody-and-chemo-29976https://curecurrent.com/trials/arfi-visr-and-ddai-ultrasound-for-improving-discrimination-of-malignant-and-unresponsive-breast-cancer-29977https://curecurrent.com/trials/comparison-of-single-agent-carboplatin-vs-the-combination-of-carboplatin-and-everolimus-for-the-treatment-of-advanced-tr-29978https://curecurrent.com/trials/high-resolution-pet-ct-specimen-imaging-for-the-perioperative-visualization-of-resection-margins-29979https://curecurrent.com/trials/an-observational-multicenter-study-evaluating-the-safety-of-real-lifepertuzumab-and-trastuzumab-fixed-dose-combination-t-29980https://curecurrent.com/trials/symptoms-associated-with-chemotherapy-induced-peripheral-neuropathy-29981https://curecurrent.com/trials/a-phase-3-randomized-placebo-controlled-trial-of-carboplatin-and-paclitaxel-with-or-without-veliparib-abt-888-in-her2-ne-29982https://curecurrent.com/trials/familial-breast-cancer-in-china-29983https://curecurrent.com/trials/early-detection-of-five-common-cancers-using-the-ctdna-analysing-test-29984https://curecurrent.com/trials/neoadjuvant-chemotherapy-plus-pyrotinib-and-trastuzumab-for-her2-positive-breast-cancer-neotorch-breast05-29985https://curecurrent.com/trials/neoadjuvant-abemaciclib-and-giredestrant-trial-in-patients-with-er-positive-her2-negative-early-breast-cancer-29986https://curecurrent.com/trials/algology-in-oncology-osteopathic-support-algos-29987https://curecurrent.com/trials/bostongene-and-exigent-genomic-insight-study-29988https://curecurrent.com/trials/radiation-therapy-palbociclib-and-hormone-therapy-in-treating-breast-cancer-patients-with-bone-metastasis-29989https://curecurrent.com/trials/evaluation-of-the-impact-of-a-pharmaceutical-interview-on-the-adherence-to-hormonotherapy-in-women-with-breast-cancer-29990https://curecurrent.com/trials/efficacy-and-safety-study-of-disitamab-vedotin-rc148-vs-albumin-paclitaxone-toripalimab-in-hr-her2-low-breast-cancer-29991https://curecurrent.com/trials/the-intestinal-microbiome-in-triple-negative-breast-cancer-treated-with-immunotherapy-29992https://curecurrent.com/trials/hydroxychloroquine-palbociclib-and-letrozole-before-surgery-in-treating-patients-with-estrogen-receptor-positive-her2-ne-29993https://curecurrent.com/trials/pharmacodynamic-study-goserelin-3-6mg-injection-administered-subcutaneously-in-premenopausal-patients-with-breast-cancer-29994https://curecurrent.com/trials/hypofractionated-radiation-fractionation-in-breast-cancer-patients-with-implant-based-reconstruction-29995https://curecurrent.com/trials/evaluation-of-the-accuracy-of-percutaneous-biopsy-by-vacuum-assisted-biopsy-vab-to-assess-pathological-complete-response-29996https://curecurrent.com/trials/reduction-of-lymphedema-secondary-to-breast-cancer-29997https://curecurrent.com/trials/tamoxifen-in-women-with-breast-cancer-and-in-women-at-high-risk-of-breast-cancer-who-are-receiving-venlafaxine-citalopra-29998https://curecurrent.com/trials/safety-and-efficacy-of-impt-or-imrt-for-breast-cancer-29999https://curecurrent.com/trials/barriers-to-therapeutic-exercise-in-breast-cancer-patients-before-during-and-after-chemotherapy-30000